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ABSTRACT
UNDERSTANDING THE RELATIONSHIP BETWEEN POSITIVE AFFECT AND
CORTISOL IN LUNG CANCER PATIENTS
Lauren A. Zimmaro
May 15, 2018
Positive psychobiological processes within lung cancer patients are drastically

understudied. This dissertation explores the nature of positive affect (PA) and potential
associations with diurnal cortisol among lung cancer patients, given the prognostic
significance of diurnal cortisol rhythms. Theoretical underpinnings and current literature
involving PA, cancer, and diurnal cortisol are first reviewed. An original integrated
model of PA and cortisol among cancer patients is then presented, from which the
proposed dissertation study and analyses are derived.
Sixty-one non-small cell lung cancer patients provided self-report assessment of
mood (PANAS PA and NA subscales, CES-D PA subscale), medical and demographic
characteristics, and 10-day salivary cortisol. Aim 1 tested hypotheses that: (1) patients
will experience moderate PA, and more PA than NA, (2) PA and NA will emerge as
separate factors in factor analyses, and (3) higher PA will correlate with variables
reflecting lower disease burden. Aim 1 was assessed through descriptive statistics,
correlations, t-tests, and exploratory factor analyses. Aim 2 tested hypotheses that: (1)
higher PA will relate to lower cortisol means, (2) higher PA will relate to steeper diurnal
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slope, (3) PA will relate more strongly to overall mean cortisol than diurnal slope. Aim 2
was tested through hierarchical linear regressions and path analyses.
Aim 1 results showed that patients generally held positive emotions and endorsed
PA items that reflected determination and resilience. They also reported more PA than
NA; these two constructs emerged as separate and distinct factors. Race, smoking, and
current treatment all significantly related to PA. Aim 2 revealed that PA did not
significantly associate with mean cortisol variables or diurnal slope. However, higher NA
was associated with flattened slopes, after excluding patients taking corticosteroids.
Although the relationship between PA and mean cortisol was consistently stronger than
with diurnal slope in path analyses, the associations were non-significant.
Patients reported experiencing positive emotions that may reflect resilience and
adaptive coping. Positive affect did not have strong associations with cortisol, which may
be due to pre-existing cortisol dysregulation or small sample size. Future studies should
continue to explore mind-body associations of positive psychological processes in lung
cancer patients.
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INTRODUCTION
The field of psychology is in the midst of a paradigm shift. For decades, the focus
of research, clinical work, and policy has been on the identification and treatment of
psychopathology. In recent years, however, attention has moved towards the other end of
the spectrum—human flourishing. This study of “positive psychology” seeks to
understand the benefits of positive emotions on mental and physical health (Seligman &
Csikszentmihalyi, 2000). Indeed, evidence of health benefits associated with positive
psychological processes is mounting (e.g., Pressman & Cohen, 2005). In healthy samples,
positive affect has been shown to independently associate with healthier physiological
processes of neuroendocrine, autonomic, and immune systems (Dockray & Steptoe,
2010). What is notably lacking, however, is a particular focus on physiological
mechanisms. Given the present evidence, this line of inquiry may have important
relevance to processes in medical disorders, yet there is a particular paucity of research in
how positive emotions relate to physiological processes in people with serious illness,
such as cancer.
The historical context surrounding the topic of positive psychology and cancer
outcomes is an emotionally charged one. The associations between positive
psychological constructs and cancer progression have typically either been
overemphasized or underemphasized, with extremes lending themselves to producing
patients’ unreal expectations of healing and/or guilt and burden. Given the vast advances
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in cancer research, a new and integrative scientific approach to this topic within the field
is both timely and necessary. Improvements in cancer treatments and outcomes shift the
focus of disease models towards those of survivorship, away from merely increasing
quantity of life to those of increasing quality of life. As such, understanding the link
between biology and positive emotional processes in cancer patients helps strengthen the
bridge between disease and survivorship models.
Positive Affect
One of the basic areas of research in positive psychology is that of positive affect
(PA). Positive affect is the subjective experience of positive moods, like joy and
happiness, stemming from pleasurable engagement with one’s environment (Clark,
Watson, & Leeka, 1989; Pressman & Cohen, 2005). These feelings may be momentary,
longer lasting, or even seemingly dispositional (Pressman & Cohen, 2005). Shorter-term
PA is referred to as “state PA” (such as joy, happiness, or pleasure) while longer-lasting
positive affect is referred to as “trait PA” (Pressman & Cohen, 2005). However, this
distinction is not always clear, and trait PA may not necessarily be best represented by an
aggregate score of state PA, as seen in some research. Instead, recent research has
highlighted the importance of considering affect variability as an indicator of mental
health (Houben et al., 2015). For both PA and NA, low variability (within-persons
standard deviation from momentary mean affect) and high stability (low change from
moment-to-moment) is associated with higher psychological well-being (Houben et al.,
2015). This distinction may be particularly important in the cancer context, as moods
may shift and reflect varying emotional demands throughout the cancer journey.
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Historically, affective valence – the degree to which emotions are considered
positive or negative – was considered bipolar, where PA was merely the opposite of
negative affect (Wundt, 1897/1998). However, as research progressed, an alternative
view of bivalence was put forth. The bivalence hypothesis follows the data supporting
that PA and negative affect (NA) are often uncorrelated and thus may be independent
constructs (e.g., Watson, Clark, & Tellegen, 1988). This view was furthered by research
supporting that PA and NA may be grounded in distinct biological systems (Cacioppo,
Gardner, & Bernston, 1999; Diener & Emmons, 1984; Diener, Smith, & Fujita, 1995;
Norris et al., 2010). As such, the presence of PA, rather than the absence of NA, deserves
unique attention.
Affect may be also described based on the dimension of arousal. The affective
circumplex model describes how emotions may be categorized based upon
multidimensional circumplex anchored by these two perpendicular scales (valence and
arousal; Russell, 1980). For example, a high arousal PA may be “excitement”, while low
arousal PA may be “relaxed.” A nuanced approach to understanding PA in regard to
arousal may have particular relevance as it relates to the body’s stress response; however,
the role of emotional arousal is typically underemphasized in mind-body research.
Researchers commonly note the lack of consensus in defining or referring to PA
(e.g., Pressman & Cohen, 2005; Dockray & Steptoe, 2010). From a historical and
philosophical perspective, PA has been categorized within two realms: hedonia and
eudaimonia. The first concept, hedonia, typically refers to the experience of state and/or
trait PA, with the absence of NA (Ryan & Deci, 2001). Hedonia also includes “subjective
well-being” (SWB) — the global tendency to experience more positive than negative
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affect, as well as judging one’s life as satisfactory (Deci & Ryan, 2008; Diener, 2000;
Howell, Kern, & Lyubomirsky, 2007). The second concept, eudaimonia, refers to overall
psychological well-being (PWB; Ryff, 1989), which includes experiences of PA, but
focuses more on living a full life of meaning and growth (Deci & Ryan, 2008; Ryff,
1989). Research supports that hedonia and eudaimonia are separate but related constructs
(Davis et al., 2015; Fredrickson et al., 2013; Keyes, Shmotkin, & Ryff, 2002; Ryff et al.,
2006; Ryff et al., 2004; Waterman, 1993). In research however, the terms referring to PA
and well-being tend to be used interchangeably, contributing to difficulty in
understanding how these factors may individually relate to physiology. An important
qualitative distinction may be made between the two concepts in how they relate to a
flourishing life: hedonia may be considered an endpoint or “result”, while eudaimonia
may be conceptualized as the “process” or “content” (Seligman, 2004).
Barbara Fredrickson (2001) proposes that PA and broader experiences of
psychological well-being are related through a “broaden and build” process. The
Broaden and Build Theory suggests that positive emotions are not just markers of wellbeing, but in fact produce it. In particular, momentary PA encourages thought broadening
(such as awareness and creativity) and approach behaviors (like play and exploration).
These momentary experiences help people to build physical, social, intellectual, and
emotional resources, which together create psychological resources. These psychological
resources are similar to the eudaimonic well-being described by Ryff (1989).
Experiencing these diverse set of resources feeds back to create more positive emotions.
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Cancer
It is difficult to find a person who has not been touched by cancer in some way in
the modern age. High incidence and mortality rates, steep costs of treatment, and physical
and emotional suffering of both patients and their social networks make cancer an area of
prominent scientific, political, and social investment. Cancer refers to a collection of
diseases all characterized by the uncontrolled dividing and spreading of cells in the body
(National Cancer Institute, n.d.) and is the second leading cause of death in the United
States (Centers for Disease Control, 2016). The complex features of tumor cells are
characterized into six “hallmark capabilities”: sustaining proliferative signaling, evading
growth suppressors, resisting cell death, enabling replicative immortality, inducing
angiogenesis, and activating invasion and metastasis (Hanahan & Weinberg, 2011).
Cancer initiation and progression is the result of multiple factors such as genetics,
immune and endocrine function, and lifestyle (Bissell & Hines, 2011). However, the
multifaceted nature of cancer extends to psychology, including the role of stress biology,
as well as the individual psychological and emotional experience of the cancer journey.
Given its implications for public health, science continues to forge forward in efforts to
understand both the biology and psychology of cancer.
Lung cancer. Lung cancer is the most commonly diagnosed cancer and the
leading cause of cancer related death among men and women worldwide (Centers for
Disease Control, 2015). Prognosis among non-small cell lung cancer patients is poor.
Five-year survival rates among early stage non-small cell lung cancer patients range from
about 53 – 92% (stage I: 68 – 92%, stage II: 53 - 60%; American Cancer Society, 2017);
however, many patients are not diagnosed until advanced stages, when the disease has
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already spread and become symptomatic (American Cancer Society, 2017). Prognosis
among late stage patients is much lower, with 5-year survival rates for stage III ranging
from 13-26% and stage IV ranging from 1-10% (American Cancer Society, 2017).
Lung cancer is met with greater distress than most other cancers (BrintzenhofeSzoc et al., 2009; Linden et al., 2012; Zabora, BrintzenhofeSzoc, Curbow, Hooker, &
Piantadosi, 2001). Patients with lung cancer experience a high symptom burden and
symptom distress, even among those who are high-functioning (Temel, Pirl, & Lynch,
2006). The most common symptoms reported include fatigue, shortness of breath, lack of
energy, and cough. Only a minority of patients respond to treatment, thus many still
endure tumor growth throughout their illness (Temel et al., 2006). Furthermore, treatment
side effects may outweigh any relief associated with disease improvement, leaving many
patients with little clinical or quality of life improvement (Temel et al., 2006).
The emotional burden of a lung cancer diagnosis is unique from other cancers.
Given the well-known link between smoking and cancer, the impact of stigma
surrounding a diagnosis often brings emotions of guilt and shame and is associated with
poorer quality of life and higher psychological distress (Chambers et al., 2012). The
compounding physical, emotional, and social burden of lung cancer is associated with
patient depression (Graves et al., 2007). As with other cancers, major depressive disorder
predicts worse survival among lung cancer patients (Pirl et al., 2012).
The coupling of poor prognosis and painful physical symptoms (e.g., shortness of
breath, chest pain, coughing up blood, weakness) make lung cancer particularly
disturbing to a patient. These patients face a difficult path of treatment, recovery, and
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physical symptoms, all in the context of potentially being at end-of-life in only a few
short years or months.
Positive Affect and Cancer
In the face of poor prognosis as well as physical and emotional disease-burden, it
may seem that experiences of joy, excitement, contentment, and other positive emotions
may be infrequent among lung cancer patients. To date, there is very little research on the
experience of positive emotions in this vulnerable population. Some of this literature
exists among samples of other cancer types; however, the paucity of research in this area
is notable (Louro, Fernández-Castro, & Blasco, 2015). One study found that advanced
cancer patients overall experienced more PA than NA on the PANAS; although, the
overall levels of PA were slightly lower than in the general population (Voogt et al.,
2005). In a recent review, PANAS scores across several cancer types indicated that
patients on average experienced low NA and moderate PA (Louro et al., 2015). Positive
affect in cancer patients seems to be associated with better general health, better social
functioning, benefit finding, low depression and anxiety (Louro et al., 2015). The review
also noted that many studies show that changes in PA are greater predictors of quality of
life and illness adaption than changes in NA (Louro et al., 2015).
Studies on the role of demographic and medical factors show mixed results,
perhaps due to the heterogeneity of cancer types and other sample factors. The role of
cancer stage or treatment factors could not be established from the available literature
(Louro et al., 2015). However, in a sample of 105 mixed-cancer patients, authors found
that older, male, lower income patients for whom surgery was planned experienced less
positive feelings than patients of other demographics (Voogt et al., 2005). Advanced
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cancer stage has been shown to correlate with lower PA, but not with eudaimonic wellbeing (Davis et al., 2015). These findings highlight that medical and demographic
variables may play a role in the experience of positive emotions; however, more research
is needed in this area, and especially within lung cancer patients.
Positive affect in cancer patients may also relate to physical, cognitive, and social
factors. Lower PA has been shown to associate with higher fatigue; and lower physical,
cognitive, and role functioning (Voogt et al., 2005). In the same study, the researchers
found that higher PA was associated with more social support and problem-focused
coping. Patients reporting higher PA experienced more meaning, peace, and perceived a
role of faith, even after controlling for demographics, coping, and symptoms. The authors
suggested that low PA may be driving distress (rather than the presence of high NA as in
psychiatric depression and anxiety) as the cancer sample showed lower PA, but similar
levels of NA, than the general population (Voogt et al., 2015). Another study drew
similar conclusions, after finding a loss of PA from diagnosis to three-month follow-up
was associated with greater mood disturbances (Hou, Law, & Fu, 2010).
Among cancer survivors, some research indicates that elements of well-being are
similar to that of healthy populations (Bradley, Rose, Lutgendorf, Costanzo, & Anderson,
2006; Helgeson & Tomich, 2005), including psychological and social well-being
(Costanzo, Ryff, & Singer, 2009). Although survivors may experience more distress than
those who have never been diagnosed with cancer (Rabin et al., 2007), PA may increase
with time since diagnosis (Costanzo, Stawski, Ryff, Coe, & Almeida, 2012). One study
showed that when survivors experienced daily stress, they demonstrated less pronounced
declines in PA than healthy control, which may demonstrate resilience (Costanzo et al.,
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2012). Together, the relationship between PA and time since diagnosis may suggest a
process of coping and resilience.
Other research suggests that feelings of joy, inner peace, and happiness are
associated with increased quality of life in patients, with joy specifically being associated
with having a more meaningful life and a good death (Lin & Bauer-Wu, 2003). Other
studies suggest that patients with positive affect also experience more meaning, peace,
and perceived role of faith (Voogt et al., 2005). Among lung cancer patients, the ability to
maintain some level of positive emotion may be a similar sign of resilience and adaptive
coping, such as through meaning-making and acceptance.
Cortisol
The role of the stress response and the hypothalamic-pituitary-adrenal (HPA)
pathway in tumor progression has become an area of significant focus in the field of
psycho-oncology. In the face of stress, the human body responds to a perceived threat via
two coordinating systems (Chrousos, 1998; McEwen, 1998). The first response is
conducted by the autonomic nervous system: rapid sympathetic nervous system
activation modulates responses such as increased heart rate and breathing, and reducing
digestion. The slower second system is the HPA axis, which has basal circadian rhythm.
The HPA response involves the integration of central nervous system components
including cortical and limbic structures, as well as blood borne signals such as hormones
and cytokines (Chrousos, 1998). When the body perceives a stressor, the HPA axis
activates a cascade of physiological processes, culminating in the release of
glucocorticoids including cortisol. Cortisol may be detected in blood, saliva, and urine;
however, the levels of detectable hormone differ between these fluids (Hellhammer,
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Wüst, & Kudielka, 2009). Cortisol is involved in a host of biological systems and
processes including the central nervous system (e.g., learning, memory, and emotion;
blood pressure, cardiovascular function), metabolic processes (e.g., glucose utilization),
and immune responses (e.g., regulating inflammatory responses; Sapolsky, Romero, &
Munck, 2000). Importantly, cortisol also plays a key feedback role in ending the stress
response, by acting on receptors in the hippocampus, frontal cortex, hypothalamus, and
anterior pituitary gland (Chrousos, 1998; Chrousos & Gold, 1992).
Salivary cortisol provides a relatively simple and reliable measure of human stress
responses, particularly in ambulatory studies, and thus is a widely used measure in
psychoneuroendocrinology (Kirschbaum & Hellhammer, 1994). In comparison to
sympathetic responses such as heart rate or blood pressure, cortisol may easily provide
data regarding external and endogenous stress reactivity data as well as longitudinal
rhythms. The HPA stress response may be measured by acute cortisol secretion after a
stressor or cortisol secretion over the day. Summary measurements may include area
under the curve (AUC) for overall secretion over time or a score such as the mean
cortisol value measured from several collection points throughout the day.
Diurnal rhythms. Cortisol follows a circadian rhythm. Levels are low in the
evening and throughout night, but rise in the morning before waking. As a proxy measure
of this rhythm, a diurnal rhythm may be estimated by calculating the slope between the
waking and evening levels of cortisol as measured by multiple salivary samples (e.g.,
Sephton, Sapolsky, Kraemer, & Spiegel, 2000). Diurnal slope is an indicator of strength
of HPA rhythmicity (Kraemer et al., 2006).

10

A second phenomenon of cortisol, known as the cortisol awakening response
(CAR), is the spike of cortisol secretion that occurs upon awakening and continues to rise
to a peak level about 20-45 minutes later (Chida & Steptoe, 2009; Pruessner et al., 1997).
The most common metrics of CAR are the mean difference in waking and peak morning
values and the slope of the increase (Chida & Steptoe, 2009). CAR is commonly used in
research to provide a unique measure of HPA activity, sparked endogenously by the
behavior of awakening, that is partially independent from cortisol secretion over the rest
of the day (Chida & Steptoe, 2009). As such, the correlation between CAR and other
cortisol values is often low (Edwards, Clow, Evans, & Hucklebridge, 2001).
Healthy cortisol functioning includes the rise and fall with normal daily stressors,
as well as general diurnal rhythmicity. Short-term cortisol responses are typically due to
acute stressors and are adaptive. Long-term alterations in cortisol responses (such as
diurnal cortisol profiles) may be due to more chronic HPA activation. Lower levels of
overall cortisol are generally seen as favorable, as they indicate low levels of stress
system activation. In diurnal patterns, steeper slopes are generally indicative of better
health, while flattened slopes and other patterns of dysregulation usually signify less
favorable health (Miller, Chen, & Zhou, 2007). Discerning “healthy” CAR is more
complex, as greater morning increases may indicate a heightened HPA response, but
findings have been inconsistent as to whether a diminished CAR is associated with better
health outcomes (Chida & Steptoe, 2009).
Recent research indicates that mean cortisol levels are more reliable than diurnal
slopes in between-subjects analyses, with the minimal reliable measurement collected
from at least three days of samples (Segerstrom, Boggero, Smith, & Sephton, 2014). Area
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under the curve and diurnal slope require more days of collection to reach reliability
(Segerstrom et al., 2014). Further, research suggests differences in overall cortisol levels
may be due to genetic influences, sex (with women demonstrating lower levels than
men), and nicotine use (Kirschbaum & Hellhammer, 1994). Thus, these factors should be
taken into account when interpreting AUC and mean diurnal secretion as indicators of
overall health.
Cortisol and Cancer
Animal and human data support the link between cortisol rhythms, cancer
incidence, tumor progression, and cancer prognosis (Eismann, Lush, & Sephton, 2010;
Sephton & Spiegel, 2003). Disruptions in cortisol and circadian rhythms are linked to
vulnerability to tumor incidence, faster tumor progression, and early mortality in cancer
patients. Data supports that both biological (e.g., genetic) and behavioral (e.g., sleep
disruption, stress) factors contribute to this link, including bidirectional relationships
between circadian rhythms, endocrine activation, immune defenses, and psychosocial
factors (Eismann et al., 2010). Research shows that 30-70% of cancer patients display
disruptions in diurnal cortisol rhythms, including uncoordinated or erratic peaks and
nadirs throughout the day, phase shifts, or generally flattened patterns at either
abnormally high or low levels (Sephton & Spiegel, 2003). Aberrant patterns are most
evident in patients with high tumor burden, poor performance status, and liver metastases
(Sephton & Spiegel, 2003). As such, disrupted cortisol rhythms may be an indicator of
progressing tumor status or the result of other biological effects of worsening
psychosocial functioning (e.g., poor sleep due to pain or anxiety; Eismann et al., 2003;
Sephton & Spiegel, 2003). However, the strongest evidence lies in the prognostic
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significance of cortisol rhythms in cancer patients. Flattened diurnal rhythms have been
shown to predict early mortality in a variety of cancers: breast (Sephton et al., 2000),
renal (Cohen et al., 2012), lung (Sephton et al., 2013), and ovarian (Schrepf et al., 2015).
Flattening of the cortisol rhythm is also observed in response to stress. In a study
of breast cancer survivors’ affective and cortisol responses to daily stressors, survivors
showed similar diurnal slopes and CAR as healthy controls, but less total cortisol on days
of daily stress (Costanzo et al., 2012). The authors suggest that this may indicate a
development of adaptive resilience or a blunted cortisol response to daily stress;
although, the clinical significance of this hyporeactivity is unclear (Costanzo et al., 2012).
Another study showed lower two-day average waking rise in cortisol in depressed breast
cancer patients when compared to non-depressed (Giese-Davis, Wilhelm, et al., 2006).
Similar results were observed with breast cancer survivors’ responses to upcoming
mammograms: survivors had similar rhythms as healthy controls, but blunted overall
cortisol on the day before and of their mammogram (Porter et al., 2003). On the other
hand, several studies suggest breast cancer patients demonstrate higher cortisol levels
than healthy controls (Abercrombie et al., 2004; McGregor & Antoni, 2009).
Positive Affect and Cortisol
Theory. The literature on the relationship between PA and physiology among
healthy populations has increased over the past decade. Several reviews have attempted
to quantify the effects (Chida & Steptoe, 2008; Dockray & Steptoe, 2010; Howell et al.,
2007; Pressman & Cohen, 2005; Steptoe, Dockray, & Wardle, 2009; Vázquez, Hervás,
Rahona, & Gómez, 2009). The overall findings indicate that PA and positive well-being
are associated with better short-term and long-term objective health outcomes in healthy
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samples (Howell et al., 2007). As evidenced in both mood induction and longitudinal
studies, for example, PA has related to longer survival and beneficial immune reponses
(Chida & Steptoe, 2008; Dockray & Steptoe, 2010; Howell et al., 2007).
PA may relate to positive health outcomes through what is known as the
“Undoing Hypothesis” (Fredrickson & Levenson, 1998; Fredrickson, Mancuso,
Branigan, & Tugade, 2000). The Undoing Hypothesis states that PA influences biology
via encouraging a quick return to physiological baseline in the face of stress. Fredrickson
et al. (2000) observed that after a stress-inducing task, participants who watched a film
provoking contentment or amusement showed faster cardiovascular recovery (e.g., heart
rate, finger pulse amplitude, blood pressure) than those who watched an a neutral or sad
film. This data is in line with earlier work finding PA is associated with lower
sympathetic activation, reflected in heart rate, skin conductance, body temperature, and
muscle tension (Levenson, Ekman, & Friesen, 1990). However, experimental studies of
the “undoing” effect of PA and on cortisol specifically are rare. The following sections
summarize the state of the current literature on the associations between PA and cortisol,
noting that nuances in state/trait PA as well as cortisol outcome measures interfere with
the ability to draw firm conclusions on this complex relationship.
Evidence in healthy samples. Despite the growing literature on the role of PA in
supporting overall health, the research on PA and cortisol is still evolving (Dockray &
Steptoe, 2010; Pressman & Cohen, 2005). The topic has been only briefly reviewed in
meta-analyses and reviews (e.g., Pressman & Cohen, 2005). Several caveats exist when
examining the current evidence. First, levels of cortisol differ in saliva, blood, and urine;
caution must be taken in comparing studies that use different cortisol measurement
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methods (Hellhammer, Wüst, & Kudielka, 2009). Second, the number of days of cortisol
collection may greatly impact reliability of results. Diurnal slopes should be measured
from at least 10 consecutive days if data are to be used for between-subjects analyses, and
from at least 5-8 consecutive days if data are to be used for within-subjects analyses
(Segerstrom et al., 2014). Third, as diurnal rhythms and CAR are controlled by distinct
biological processes, waking samples used for calculating diurnal slope must be anchored
at the actual time of waking – e.g., not 30 minutes post-waking (Kraemer et al., 2006).
Calculating slopes anchored beyond waking increases the risk of inflating or deflating the
true diurnal slope value.
To calculate diurnal cortisol slope, one should therefore first exclude the postwaking cortisol sample from the analyses. Then, all remaining log-transformed cortisol
points (waking, bedtime) should be regressed on collection time (numeric, hours). The
cortisol points should be from the entirety of the collection period; an average of daily
slopes should not be used, as it contributes to data smoothing. The diurnal slope is
represented by the unstandardized beta from the regression of all waking and bedtime
points onto time (e.g., Turner-Cobb et al., 2000).
State PA and overall cortisol levels. Initial evidence supports that increased state
PA is associated with low cortisol secretion; however, reviews note that there are some
inconsistencies. Pressman and Cohen (2005) found that when PA was induced in
laboratory studies, acute cortisol typically decreased or showed no change; however, a
few studies showed that cortisol levels increased. These inconsistencies may be the result
of different methods of cortisol measurement, for example via plasma (e.g., Brown et al.,
1993; Codispoti et al. 2003) versus saliva (e.g., Hubert et al., 1993; Hubert & Jong-
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Meyer, 1991). Sampling times also ranged, such as from just pre-post (Hucklebridge et
al., 2000) to every 15 minutes throughout induction (e.g., Hubert & Jong-Meyer, 1991).
Sample sizes for theses studies have been typically small (N < 25), which may also
contribute to inconsistencies.
State PA and diurnal rhythms. The association between diurnal cortisol rhythms
and state PA is noteworthy. As previously reviewed, cortisol exhibits a predictable
diurnal rhythm in healthy functioning: a peak about 30 minutes upon awakening,
followed by a relatively steady decline throughout the day. Interestingly, PA follows a
similar temporal pattern to that of the cortisol diurnal rhythm: positive emotions tend to
peak early in the day and then substantially decline in the evening (Clark et al., 1989;
Simpson et al., 2008; Thayer, 1987, 1989). NA, however, shows no such systematic
diurnal rhythm (Simpson et al., 2008; Watson, Wiese, Vaidya, & Tellegen, 1999). This
differentiation in diurnal affect patterns echoes the notion that NA and PA have distinct
biological systems. Dockray and Steptoe (2010) note that studies do indeed find a
coupling of diurnal cortisol patterns and PA. Furthermore, PA shows a similar pattern to
other endogenous processes, including body temperature and sleep-wake cycles (Watson
et al., 1999).
Trait PA and overall cortisol levels. Among several large-scale studies, higher
levels of trait PA tend to be associated with lower total cortisol secretion. One early study
of 216 healthy adults showed that higher trait PA (as aggregated over several days) was
associated with lower levels of overall cortisol secretion, even after controlling for age,
gender, SES, BMI, smoking, and distress (Steptoe, Wardle, & Marmot, 2005). These
findings were replicated in a later sample of 2,873 adults (Steptoe, O'Donnell, Badrick,
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Kumari, & Marmot, 2008). Reviews mirror this notion, observing that PA is indeed
typically linked to lower overall daily cortisol levels (Dockray & Steptoe, 2010;
Pressman & Cohen, 2005; Steptoe, Dockray, & Wardle, 2009).
Trait PA and diurnal rhythms. Studies on trait PA and diurnal rhythms show
somewhat mixed findings, largely resulting from methodological issues. For example,
one study found that trait PA and diurnal rhythms differed by gender: men with low trait
PA showed flattened, but high, cortisol levels throughout the day, and women with high
trait PA showed flattened patterns of low cortisol (Polk et al., 2005). However, salivary
cortisol was sampled only over one 24-hour period, and diurnal slope calculations were
anchored with a post-waking sample. Another study found that that eudaimonia, but not
hedonia, was associated with the low, flattened patterns of cortisol (Ryff et al., 2004).
However, the study again presented methodological issues with cortisol slope calculation
by anchoring with a post-waking sample and averaging daily slopes together, thus
contributing to data smoothing and minimizing the robustness of the data. Overall,
caution is warranted in interpreting such results.
Recent work attempts to elucidate the role of affect variability in the PA/cortisol
relationship. Human et al. (2015) conducted two studies, which in aggregate suggested
that less favorable cortisol profiles were associated with having either too much or too
little PA variability. Flattened slopes and high cortisol means were associated with high
within-day PA variability among middle age adults, and with low across-week PA
variability among older-adults. The findings highlighted that variability in PA may relate
to certain cortisol profiles.
The evidence surrounding the role of arousal in the relationship between affect

17

and cortisol is another area of growing interest. Item level analyses in the middle aged
sample of Human et al. (2015) showed that alert was a stronger predictor of cortisol than
the affects good and relaxed, highlighting the potentially important aspect of arousal in
the PA/cortisol relationship. Another recent study highlighted a similar pattern of
affective arousal on cortisol findings (Hoyt, Craske, Mineka, & Adam, 2015). A large
sample of adolescents (N = 315) provided salivary cortisol samples and affective state
ratings six times a day for three consecutive days. Principle component analysis
identified four uncorrelated factors from mood ratings: positive/high-arousal (e.g., alert),
positive/low-arousal (e.g., relaxed), negative/high-arousal (e.g., stress), and
negative/low-arousal (e.g., sad). Analyses indicated that stronger positive/high-arousal
was associated with steeper diurnal slope. Participants with positive/high-arousal had
lower bedtime cortisol, but only at higher levels of PA intensity. Positive/low-arousal was
not associated with cortisol. As such, a measure such as the Positive and Negative Affect
Schedule (PANAS; Watson et al., 1988) may serve as a strong scale to capture such
associations, given its inclusion of many high-arousal items (e.g., determined,
enthusiastic, active).
A recent large-sample study builds evidence that high trait PA is associated with
stronger cortisol rhythmicity. Using a sample of 490 healthy adults, Miller et al. (2016)
measured personality and trait PA through self and observer rating scales. Participants
provided five salivary cortisol samples (waking, +30mins, +4hours, +9hours, bedtime)
over four consecutive days. Cortisol values were log-transformed and regressed onto
time. Slope calculations were anchored at waking but still included the 30-minute postwaking sample, thus should be interpreted with some caution. Structural equation

18

modeling assessed the association of positive emotionality (extraversion/PA) with
cortisol, and found a positive association with positive emotion with steeper slopes and
smaller CAR, but no association with overall cortisol levels.
Overall, the literature on PA and diurnal slopes should be considered cautiously,
due to methodological concerns. Although evidence points to a general trend of steeper
slopes associated with higher PA, aspects of affect variability and arousal may be
confounding results. Methodological rigor is needed in calculating slopes in order to
ensure true diurnal rhythms are represented, and not muddied by the anchoring by or
inclusion of CAR samples.
Summary. The growing literature on PA and cortisol among healthy samples
shows some promise of true association; however, all results must be considered
critically in regard to methodology and the role of affect variability and arousal. First,
state inductions of PA show evidence that increased PA is associated with lower cortisol
levels. Second, diurnal state PA follows a similar temporal pattern as diurnal cortisol.
Third, higher trait PA may be associated with lower total cortisol secretion. Fourth,
higher trait PA may be associated with steeper cortisol slopes and smaller CAR. Greater
methodological rigor is warranted including enduring a minimum of several collection
days, anchoring slope at waking, and excluding post-wake samples in slope calculation
(Kraemer et al., 2006; Segerstrom et al., 2014).
PA and Cortisol in Cancer Samples
The quality of the relationship between PA and cortisol may differ between
cancer and healthy samples in clinically meaningful ways. Receiving a cancer diagnosis
results in a range of emotional experiences, more intense and complex than one would
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experience under normal, healthy conditions. Thus, the stress of having cancer may
significantly alter the quality of emotional experiences. Indeed the majority of research
on affect in cancer focuses on negative experiences such as distress and depression. The
paucity of research on PA in cancer patients is remarkable, and highlights a gap in the
field. Given that relatively little is known about PA in cancer patients in general, the
exploration of biological correlates makes for an even more elusive topic (Davis et al.,
2015). Another critical point is that neuroendocrine function is altered when the body is
fighting tumors (Sephton & Spiegel, 2003). Thus, findings from research of cortisol
function in healthy populations may not be fully valid among cancer samples, but may
nonetheless be informative.
To my knowledge, only four studies have investigated the association of PA and
cortisol in cancer patients (Table 1). The first study compared a sample of breast cancer
survivors to healthy controls (Porter et al., 2003). Longitudinal data assessed whether
predicted changes in cortisol slope, overall mean levels, and reactivity to a cancerspecific stressor (mammogram). Cortisol and psychosocial data were collected for three
days at baseline (one month before mammogram), and for three days at the time of the
mammogram (day before, of, after). Baseline slope was calculated via a nested, mixedlinear model. Slopes were not calculated for the one-day stress samples; instead, cortisol
reactivity was calculated as the slope from regressing average cortisol level during the
stress days onto baseline. The authors found that higher baseline PA was associated with
lower cortisol reactivity to mammogram when compared to healthy controls.
The second study was a cross-sectional investigation on whether emotional
expression was related to healthier cortisol rhythms among metastatic breast cancer
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patients (Giese-Davis, DiMiceli, Sephton, & Spiegel, 2006). Metastatic breast cancer
patients were videotaped during the first session of expressive-supportive group therapy
and provided salivary cortisol samples (three days, four samples per day). Hierarchical
linear regressions assessed the relationship between PA expression and diurnal cortisol
slope and average cortisol. Similar to the findings from Porter et al. (2003), the authors
found that increased positive emotional expression (affection, humor, joy, etc.) was
related to lower mean cortisol levels, even after controlling for negative emotional
expression. NA expression, but not PA, was associated with steeper diurnal slope.
The third study was conducted by the same group and explored depression and
stress in metastatic breast cancer patients (Giese-Davis, Wilhelm, et al., 2006). The
overall findings of that study indicated that depressed cancer patients had less PA and
lower waking cortisol levels. However, no direct analyses were conducted between PA
and cortisol, thus no conclusions can be drawn about their relationship from that study.
The fourth study was on a sample of breast cancer survivors (Costanzo et al.,
2012). Drawing from a large national survey, survivors were age, sex, and education
matched to healthy controls. Cortisol was measured via four samples per day, over four
days; slopes were anchored at waking. Findings showed that longer time since diagnosis
was associated with higher levels of PA and lower levels of total cortisol. However, the
relationship between PA and cortisol was not directly measured, thus conclusive
associations may not be drawn. Nevertheless, it may be that longer time since diagnosis
allows for more space for successful coping, reduced immediate distress about treatments
or even reoccurrence, thus improving PA and reducing overall physiological stress.
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Indeed some studies have shown that meaning of life scores may increase over time in
cancer patients (Hsiao et al., 2013).
Costanzo et al. (2012) also found that on days where daily stressors occurred,
cancer survivors showed less pronounced decline in PA and lower overall cortisol levels,
but similar patterns of diurnal cortisol slope and CAR in comparison with healthy
controls. Again, the direct relationship between PA and cortisol was not specifically
assessed. Nevertheless, the results demonstrate an element of emotional resiliency among
cancer survivors in that they maintained some PA and low HPA reactivity in the face of
stress. The analyses suggest some degree of relationship between experiencing stress,
maintaining PA, and minimal disruption of cortisol patterns.
Summary. In light of the minimal amount of published research on PA and
cortisol in cancer patients, firm conclusions may not be made. Nevertheless, initial
patterns do appear in the work presented and may inform future hypotheses. Specifically,
state and trait PA seemed to relate to overall cortisol levels in these samples of cancer
patients. In particular, cancer patients who had high PA showed lower overall cortisol
levels, even in times of cancer-specific stress. Unlike the findings among the healthy
literature, PA did not seem to show a firm relationship with diurnal cortisol rhythms in
these samples of cancer patients. As with healthy samples, conclusions on CAR cannot
be drawn.
Limitations of Current Literature
A review of the current literature on PA and cortisol sheds light on several
limitations in these cancer studies. Several of the limitations are common to those
observed in research among healthy samples as well.
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Measuring PA. Lack of standard measures and interchangeable terms referring to
PA and well-being leads to concerns of reliability and validity. Without consistent
application of the term “PA”, especially as it relates to broader concepts of subjective
well-being and eudaimonia, the nuanced associations of PA with biology will be lost.
However, one of the most common measures of PA is the Positive and Negative Affect
Schedule (PANAS; Watson et al., 1988), which is used throughout the healthy and cancer
literature.
Furthermore, the lack of differentiation between state and trait PA invokes
confusion in understanding underlying physiological mechanisms (Pressman & Cohen,
2005). Affective states are closely associated with central nervous system activation,
relating directly to both neuroendocrine and cardiovascular functioning (Critchley, 2005),
while positive traits such as optimism may affect physiological processes by inducing
successful coping strategies (Scheier, Carver, & Bridges, 2001). Measuring self-reported
average affect over a brief, set amount of time (e.g., using the PANAS anchored to the
past week) may be one method to overcome this issue. Such an approach may be a more
valid way of capturing affective experiences by honoring the emotional fluctuations that
may occur (for example, week by week with treatment schedules) throughout the cancer
journey.
Measuring cortisol. Reliable collection and calculation of cortisol remains an
issue across research among both healthy subjects and cancer patients. For example,
many studies include post-wake samples in their calculation of cortisol slope or use too
few of days to reliably calculate the cortisol variables. Reporting of multiple cortisol
metrics is also imperative, given that overall secretion levels, CAR, and diurnal slope
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capture different, and somewhat independent, processes (Chida & Steptoe, 2009; Wüst,
Federenko, Hellhammer, & Kirschbaum, 2000). For example, mean cortisol levels
provide no information as to how steep or flat as slope is.
Sample and design issues. All four of the studies on PA and cortisol in cancer
were on breast cancer patients, limiting generalizability to other cancer samples, and in
extension, to samples that include males. Gender associations with cortisol may have
influenced the findings of the studies, as gender effects are seen in overall cortisol levels
(Kirschbaum & Hellhammer, 1994), CAR (Clow, Thorn, Evans, & Hucklebridge, 2004),
and slope (Human et al., 2015). Lack of generalizability extends to several of the healthy
sample studies as well, with some having strikingly small samples sizes (e.g., 5
experimental participants and 5 controls, all men; Berk et al., 1989), all one gender, or of
a certain age range (e.g., Ryff et al., 2004; Steptoe, Gibson, Hamer, & Wardle, 2007).
More research is needed with other cancer samples, such as lung cancer, that are
inclusive of both genders, wide age range, and have larger sample sizes.
A final and related critique of the current literature is that studies differ on the
control variables used in analyses. Costanzo et al. (2012) could not control for certain
cancer-specific variables since the data came from a large-scale aging study where these
variables were not assessed. The other cancer studies did not use control variables in
primary analyses or used analyses that did not allow for them. Most importantly, NA is
not consistently controlled for in both healthy and caner studies (Steptoe et al., 2009).
Accounting for the effects of NA is essential to understanding the unique contributions of
PA in salutary biological effects. Other potential confounding variables that associate
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with PA include gender (as previously discussed), age (Mroczek & Kolarz, 1998), socioeconomic status (Diener & Biswas-Diener, 2002), and education (Keyes et al., 2002). 	
  
A Cancer-Specific Integrated Model

	
  

While the literature on physiological processes associated with PA in healthy

samples is in its infancy, research among cancer patients can highlight important
processes and outcomes. In this light, I present an original integrated model driven by
theory and based on the previously reviewed literature (Figure 1). I propose that, in
cancer patients, PA and eudaimonia differentially interact with distress effects on the
brain and HPA system, and that these effects are different from those seen in healthy
samples. Neurobiological mediators are presented, yet an in-depth review of them is
beyond the scope of this paper. The model is presented to create a context for more
specific future research and to spark foundational research upon which to build.
Pressman and Cohen (2005) suggest that PA may have a direct effect on HPA
functioning in healthy samples. However, in cancer patients, PA alone may not be strong
enough to have a main effect on biology. The direct effects of PA on the HPA may be
masked in cancer due to increased psychological stress, as well as tumor and treatment
effects on physiology. Pressman and Cohen (2005) put forth a second model that suggests
PA works indirectly on biology through buffering stress and immune responses.
However, the model lacked specific theories of mechanisms, did not include the role of
neurobiological components, and was not cancer specific. Thus, my proposed model
captures these elements to present how PA may relate to cortisol in cancer patients.
Cancer patients experience distress (Zabora et al., 2001; Figure 1, arrow A).
Perceived stress affects the HPA system (Chrousos, 1998; arrow B) and other emotion-
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related brain structures including the prefrontal cortex (PFC), ventral striatum, amygdala,
and hippocampus (Arnsten, 2009; arrow C). These areas of the brain may also interact
with HPA function (Chrousos & Gold, 1992; Dedovic et al., 2009; Kern et al., 2008;
arrow D). Evidence is building that positive psychological processes may have main
effects with these same brain regions (arrows E and F). Positive affect may stem from the
activation of “hedonic hotspots” in the limbic system and cortex, thus producing the
experience and awareness of state positive emotions (Kringelbach & Berridge, 2009).
The chronic experience of state PA (i.e., trait PA) then in turn strengthens these systems
(Kringelbach & Berridge, 2009). Increased PA is associated with increased left
frontocentral activation (Urry et al., 2004), while eudaimonic processes are associated
with the frontal cortex, amygdala, insula, and cingulate cortex (Heller et al., 2013; Lewis
et al., 2014; Urry et al., 2004). In relation to the HPA, people with greater ability to
maintain activation in brain reward systems (i.e., PFC and striatum) demonstrate higher
PA, greater eudaimonic well-being, and lower overall cortisol levels (Heller et al., 2013).
The experience of PA broadens one’s cognitive and behavioral repertoire, leading
to a building of physical, social, intellectual, and emotional resources (“Broaden and
Build”; Fredrickson, 2001). This creation of wide spreading psychological resources
mirrors the concept of building eudaimonic well-being (Ryff, 1989). Engaging in these
resources then feeds back to creating more positive emotions. This “Broaden and Build”
process is evident in cancer patients (arrow G). Feelings of joy, inner peace, and
happiness are associated with increased quality of life in patients, with joy specifically
being associated with having a more meaningful life and a good death (Lin & Bauer-Wu,
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2003). Other studies suggest that patients with higher PA also experience more feelings
of meaning and peace (Voogt et al., 2005).
If PA and eudaimonia indeed interact to build each other, their unique effects on
cortisol in cancer may be difficult to parse out. Nevertheless, I propose that PA and
eudaimonia, although interrelated, produce different cortisol outcomes based on two
different, theoretically-driven mechanisms. First, the research suggests that state and trait
PA relate to cortisol reactivity (i.e., total cortisol secretion), but perhaps not as strongly to
cortisol slopes, in cancer patients. I propose this may be due to Fredrickson’s “Undoing
Hypothesis” (Fredrickson & Levenson, 1998; Fredrickson et al., 2000; arrow H1). The
Undoing Hypothesis suggests that the experience of PA in the face of stress helps the
body return to a physiological baseline faster than neutral or negative emotions do. In this
way, state PA (and by extension trait PA) may work to “undo” similar HPA stress
responses, by activating parts of the brain such as the PFC and hippocampus that help
initiate the stop of cortisol production (Chrousos & Gold, 1992). In other words, once a
stressor is faced, patients who also experience PA are better able to discontinue the stress
response, thus allowing for a lower accumulation of total cortisol (arrow H2).
PA in this sense may be conceptualized as a “short term” process, by preventing
accumulation of cortisol through “undoing” the negative physiological effects of acute,
rather than chronic, stress. Indeed stressors in the cancer studies may be described as
short term: daily stressors (Costanzo et al., 2012), current discussion of cancer-related
topics (Giese-Davis, DiMiceli, et al., 2006), or a cancer-related stressor happening the
next day (Porter et al., 2003). Of note, the women in Costanzo et al. (2012) endorsed
experiencing stress, but still maintained high PA, and showed lower overall cortisol
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output. Although stress perceptions were not directly measured in the other studies,
similar processes may have been at play, as they too observed that patients with high PA
showed lower total cortisol levels (Giese-Davis, DiMiceli, et al., 2006) and lower cortisol
reactivity (Porter et al., 2003) to their cancer-related stressors. Given that trait PA may be
conceptualized as the frequent and consistent experience of state PA, one might consider
too that trait PA would also be associated with lower levels of overall cortisol because of
this undoing process.
Despite evidence among healthy samples, there is a lack of firm support that PA
may relate to longer-term cortisol outcomes such as diurnal rhythms. Since this point is
drawn from only four studies of breast cancer patients, more research is certainly needed
in this area. However, it may be that eudaimonia, a more enduring process that involves
building coping skills and psychological resilience, is a more potent positive
psychological process than PA alone in cancer patients. Eudaimonia is therefore more
likely buffer the effects of stress, through using broad psychosocial resources to
adaptively adjust appraisals, coping, and emotional outcomes (arrow I1; Fredrickson,
2001). This buffering effect is likely to influence biological indicators of chronic (rather
than acute) distress, such as disrupted diurnal rhythms (Figure 1, arrow I2). Although a
thorough review of studies was outside the scope of this paper, initial evidence exists that
improving experiences of eudaimonia, such as meaning making through psychotherapy,
results in steeper cortisol slopes in cancer patients (Hsiao et al., 2012). Extending from
this, a recent study on hedonia and eudaimonia in ovarian cancer patients utilized
structural equation modeling and found that eudaimonia was associated with lower tumor
norepinephrine; however, PA was not (Davis et al., 2015). It may be that although PA
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and eudaimonia are related, the more enduring processes involved with building
eudaimonia may be more strongly associated with robust biology (e.g., diurnal rhythms)
than PA alone.
It also remains unknown if total cortisol output relates to diurnal slopes in a
similar way that PA relates to eudaimonia – that they are proxies of each other and work
in a feedback process (Fredrickson, 2001). Indeed, the relationships between cortisol
output and diurnal slope are yet to be fully understood in cancer patients (Giese-Davis,
DiMiceli, et al., 2006). As PA works to produce eudaimonia through Fredrickson’s
Broaden and Build theory, it may be that the respective effects on cortisol work in a
similar way. If a patient is better able to maintain low cortisol reactivity (i.e., low means
and quick return to baseline HPA function), the patient may in turn see an overall
maintenance of cortisol rhythms and a preservation of steeper slopes. The PA and
eudaimonia relationship may work in parallel to the cortisol output and cortisol
rhythmicity relationship.
The final stage of the model relates to long-term outcomes. Psychological
resilience in the short-term (PA and overall cortisol) coupled with resilience in the longterm (eudaimonia and diurnal rhythms) work jointly to influence other downstream
processes, such as inflammation. These psychoneuroimmune and endocrine processes
then relate to health outcomes such as disease progression, survival, and quality of life
(Lutgendorf & Costanzo, 2003).
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THE PROPOSED STUDY
Given the state of the current research, PA seems to relate to biology in
meaningful ways. However, the relationship to cortisol may differ between cancer
patients and the healthy population. Due to cortisol’s particular importance in cancer
outcomes, this topic deserves greater attention. While PA seems to be associated with a
broad range of cortisol outcomes in healthy samples, data from cancer patients
demonstrate more limited associations, implying that certain positive experiences may be
related to specific cortisol responses or that mind-body relationship may be masked by
disease-related variables. The integrated model highlights recent research on
neurobiological pathways as well as theoretically-driven mechanisms. Future research
will clarify these processes, leading to improvements in clinical applications and policy.
To help begin filling in the scientific gap concerning the PA/ cortisol relationship
in cancer patients, the current study will focus on the proposed direct pathway between
PA and cortisol (Figure 1, arrow H2; Figure 2). The study will use a sample of lung
cancer patients, given the relative paucity of literature on psychobiological processes in
this vulnerable population. The study will test the association between PA experienced
over the past week and subsequent cortisol outcomes over the following ten days.
Research Question and Hypotheses
Aim 1. Understand the frequency and quality of PA among lung cancer patients.
Explore what elements of the person (e.g., demographic variables) and his or her cancer
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journey (e.g., medical variables) may be associated with experiencing more positive
affect. The primary research question is: What positive emotions, and to what degree, do
lung cancer patients experience in a given week? What are the demographic and medical
variables that may relate to experiencing more positive affect among these patients?
Hypothesis 1.1. Positive affect in this sample will be described at an item,
subscale, and construct level. Patients will experience moderate PA, and patients will
report more PA than NA, as tested by the PANAS.
Hypothesis 1.2. In exploratory analysis, positive and negative affect items will
emerge as separate factors.
Hypothesis 1.3. Variables that reflect lower disease burden (e.g., lower stage, no
current treatment, longer time since diagnosis) will be associated with higher PA.
Aim 2. Test the relationship between positive affect and cortisol outcomes. The
primary research question is: Does positive affect relate to diurnal cortisol measures in
lung cancer patients?
Hypothesis 2.1. Higher PA will be related to lower mean cortisol levels.
Hypothesis 2.2. Higher PA will be related to steeper diurnal cortisol slope.
Hypothesis 2.3 PA will more strongly relate to mean cortisol than to diurnal
slope.
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METHOD
Data were collected as part of a larger study investigating the prognostic
significance of circadian disruption in lung cancer patients and the utility of a
mindfulness-based coping skills intervention (University of Louisville IRB 13.0508).
Recruitment
Study personnel were trained by the University of Louisville to ethically conduct
human subjects research. The University of Louisville and the James Graham Brown
Cancer Center provided hospital accreditation to recruitment personnel in order for them
to have patient contact in the clinic. Lung cancer patients were recruited for the study
from thoracic oncology clinic at the James Graham Brown Cancer Center in Louisville,
KY. Recruitment personnel reviewed all patients listed on the clinic’s outpatient schedule
and assessed each patient’s eligibility through the use of a standardized screening chart
review. The chart review included a summary of inclusion/exclusion criteria as well as
other relevant medical and demographic factors. Attending physicians were made aware
of which patients met study criteria. Physicians then briefly introduced the study to
potential participants after their appointment, at which time the recruitment personnel met
with the patient. Patients were given information regarding the purpose and requirements
of the study, presented with opportunities to ask questions, and invited to provide consent
for participation. If the patient enrolled, the recruitment personnel worked closely with
the patient to explain the instructions for data collection and the process of the study in
detail.
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Participants
Patients were recruited between February 2014 and October 2016. To have met
study eligibility criteria, patients must have been between the ages of 18 to 85, have
received a diagnosis of non-small cell lung cancer with the previous five years, have no
concurrent medical diagnosis likely to influence short-term (i.e., six-month) survival, live
within a 120-mile radius of Louisville, KY, have no history of psychiatric hospitalization,
no history of drug or alcohol abuse within the previous two months, and no known
immune compromising conditions such as hepatitis or HIV/AIDS. Sociodemographic
and cancer related history and treatment variables were derived from chart review at the
time of eligibility assessment.
Ninety-three patients were invited to participate in the study during the
recruitment period. Of those invited, 67 chose to enroll at baseline. Six of these patients
withdrew during baseline collection for reasons such as current health issues or current
social stressors. The final sample of patients for the current study was therefore 61
patients. Full cortisol data was completed for 57 of these patients.
Data Collection Procedure
Informed consent. All study procedures were conducted in accordance with
guidelines set forth by the University of Louisville Human Subjects Protection Program.
All study participants provided informed consent and Health Information and Privacy
Protection Act (HIPPA) documents prior to enrollment.
All participants were enrolled in a larger study examining the prognostic
significance of circadian disruption in lung cancer and the utility of a piloted
mindfulness-based coping skills intervention. Data for the current study consisted only of
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baseline data collection. After informed consent, participants were provided with a
baseline questionnaire packet, a ten-day daily brief questionnaire packet, a salivary
cortisol collection kit containing 20 salivary collection tubes (“salivettes”; Walter
Sarstedt Inc., Newton, North Carolina), and a wrist-worn actigraphy watch. A trained
phlebotomist drew three vials of blood for assessment of immune and metabolic
functioning. Participants were compensated with a $100 pre-paid gift card for completing
baseline data collection in full. Participants were invited to participate in a mindfulnessbased coping skills intervention over the following three months, and a follow-up
assessment similar to baseline after completing the intervention.
Demographic and medical variables. Demographic and medical history
variables were derived from the medical chart at the time of recruitment. Participants
were also instructed to complete a set of demographic items in the beginning of the
baseline questionnaire packet.
Psychosocial questionnaires. Participants were asked to complete a set of
psychological measures consisting of both risk and resilience factors, which took about
an hour and a half to complete. As part of this questionnaire packet, participants
completed the Positive and Negative Affect Schedule (Watson et al., 1988) coded to
assess affect over the past week. Participants also were given a ten-day daily
questionnaire packet, consisting of brief questionnaires on variables that may affect
cortisol (e.g., sleep, medications); these questionnaires took about 10 minutes to complete
each day.
Salivary cortisol. The daily questionnaire packet provided detailed instructions
on salivary cortisol collection, as well as a supplemental document for the participant to
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note any deviations from the data collection protocol. Participants were provided with a
salivary cortisol collection kit. The kit includes 20 pre-labeled salivettes, each labeled
with a sticker for recording the participant’s identification code, exact time of saliva
sample, and the date. Salivettes were organized by sample time and day of collection in
the kit. The kit was provided in a large zip-lock bag and included a sharpie marker to
maximize participants’ ability to accurately record data on the salivette. Participants were
instructed to provide two salivary samples each day for ten consecutive days: one sample
immediately upon awakening and one sample at bedtime. To provide a saliva sample,
participants removed the cap from the salivette and placed the entire cotton swab in their
mouth, keeping the swab there until it was fully saturated (about two minutes). While the
swab was in their mouth, participants noted their identifier code, and the exact time and
date on the salivette, using their actigraphy watch as a reference point. Participants then
spit the saturated swab back in the salivette tube and closed the cap tightly. Participants
then placed the fully labeled sample in the zip lock bag and kept all collected samples in
the refrigerator. All saliva samples are kept refrigerated until they are returned to the lab
for processing.
Recruitment personnel suggested that the cortisol collection kit be kept at the
participant’s bedside in order to maximize the ease and reliability of collecting the
morning sample immediately upon awakening. To ensure accuracy of data collection,
study personnel emphasized to the participants that the morning saliva samples must be
taken at the moment of awakening. Any delay in this sample will result in an inaccurate
waking cortisol value and may instead capture CAR. Participants were reminded of the
importance of recording the exact time of all saliva samples on the specified label on the
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salivette. They were instructed not to eat, drink, smoke, chew gum, or brush teeth 30
minutes prior to any saliva sample, which minimizes any risk of contaminating the
cortisol data. They were advised to note any late sample takings, difficulties they had, or
accidental contaminations of any saliva sample on a supplemental document provided
with the daily questionnaire. Study personnel called the participant around the third day
of the 10-day collection to check in on the status of data collection and clarify any
questions or concerns the participant may have had.
Data retrieval. During the data collection, study personnel contacted the
participant to schedule a time to meet and collect the baseline data and provide the $100
prepaid gift card. At the scheduled meeting, all study materials were returned. The
participant was compensated and was instructed on further study protocol (i.e.,
intervention and three month follow-up). The study personnel returned to the lab on the
University of Louisville Belknap campus to file the questionnaire data and begin
processing the biological data.
Cortisol assay. Once salivary cortisol samples were returned to the lab, they
remained refrigerated until prepared for assay. All saliva samples were processed within
one month of the first sample, but typically within a few days of the last sample.
Salivettes were centrifuged for 15 min at 453 g at 25 °C. Any abnormal appearance in the
cotton or saliva was recorded. Samples were pipetted into microcentrifuge tubes, placed
in freezer boxes, and frozen in a -80 °C freezer until assayed. The cortisol levels were
assayed using an enzyme-linked immunoabsorbent assay (ELISA) developed for use in
saliva (Salimetrics, Inc., State College, PA). Along with participant assay results, samples
of known high and low concentration cortisol were evaluated to obtain reliability
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estimates for the assay. Assay sensitivity was 0.007 µg/dL. The average inter-assay and
intra-assay coefficients of variation (CV) were under 10% for both the low and high
controls.
Measures
Demographic and medical data. In order to explore demographic and cancerrelated individual difference factors associated with PA, an array of variables were
collected during medical chart review and in the baseline questionnaire packet.
Demographic variables included age, gender, race/ethnicity, household income, and years
of education. Medical variables of interest included age at diagnosis, cancer stage,
smoking history, current or past treatment (radiation, chemotherapy), and current
medications. Cancer stage and date of diagnosis were confirmed through chart review.
There were no missing data for medical and demographic variables, except smoking. One
individual opted not to answer current smoking status. Of patients with a smoking history
(n=59, including current smokers), four did not answer how many years they smoked (the
distribution remained normal). Smoking history was quantified as pack-years, which is
the number of packs of cigarettes per day multiplied by years smoking. Four current
smokers indicated a difference between current pack years and historical pack years, all
showing a decrease in current smoking; in these cases, historical pack years was used as
their total pack years number to account for smoking over the lifetime. Control variables
used in Aim 2 analyses were derived through theoretically-based and data-driven
verification.
Positive affect. The Positive And Negative Affect Schedule (PANAS) was the
primary measure used to assess affect (Watson, et al., 1988). The PANAS is a 20-item
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self-report measure, which assesses positive and negative affect scores on a five-point
scale ranging from very slightly or not at all to extremely. The total score from the ten
positively valenced items and the ten negatively valenced items comprise the PA and NA
subscales, respectively. The PA subscale reflects the extent to which the participant feels
positive mood states such as, “inspired”, “interested”, and “excited”. The NA subscale
captures aversive mood states such as “irritable”, “guilty”, and “scared”. The PANAS
may be coded to either momentary affect, general affect experienced over the past week,
or other set timeframes; the PANAS was coded to the past week in this current study. The
measure was originally validated and developed in an undergraduate sample. The internal
consistency of the measure is excellent, with alpha coefficients for the PA scale ranging
from .86 - .90, and for the NA scale ranging from .84 - .87 (Watson et al., 1988). The
PANAS has been used in cancer populations, with alpha coefficient of the PA scale at .88
and of the NA scale at .91 (Manne & Schnoll, 2001). The PA-NA inter-correlation ranges
from -.12 to -.23, indicating quasi-independence between the subscales (Watson et al.,
1988). The test-retest reliability for the PANAS coded to the past week is .47 for both PA
and NA (Watson et al., 1988).
The positive affect items of the Center for Epidemiologic Studies Depression
scale (CES-D) were used as a secondary measure of PA. The CES-D is a popular,
standardized measure used to assess depressive symptoms (Radloff, 1977). It is
comprised of a total of 20 items: 16 items measuring depressive symptoms and behaviors,
and four items assessing positive affect. Participants are asked to rate the frequency of the
feelings or behaviors over the past week. Items are scored on a four-point Likert scale,
ranging from Rarely or None of the Time to Most or All of the Time. Total score is
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comprised of the sum of the depressive symptoms items and the reverse score of the
positive affect items. The measure has high internal consistency (alpha coefficients
ranging from .85 - .90).
The positive affect items of the CES-D include: I felt that I was just as good as
other people, I felt hopeful, I was happy, I enjoyed life. These items were originally
added to the CES-D in order to break tendencies towards response set and to assess the
absence of PA in depressed people (Radloff, 1977). However, in a large sample of both
cancer (n = 434) and healthy controls (n = 236), factor analysis found that these PA
items consistently loaded onto a separate factor that had relatively low correlation with
the depressed affect scale (r = .14), which is consistent with other factor analysis studies
(Schroevers et al., 2000). These findings suggest that the PA items of this measure likely
represent a construct independent of depression (i.e., positive affect, rather than the
absence of depressive symptoms). Cronbach’s alpha for PA in that study was 0.75 for the
cancer sample and 0.76 for healthy controls (Schroevers et al., 2000). Therefore, in the
current study, the total score of PA items (not reverse scored) on the CES-D was used as
a secondary measure of PA (CES-D PA). This secondary measure of PA served as both
construct validity for PANAS-PA as well as a method to expand the span of arousal that
could be captured between the PANAS and CES-D PA items.
In both psychosocial measures (PANAS, CES-D PA), data were reviewed for
outliers. Missing data was addressed through imputation. Consistent with the laboratory
protocol for missing data, no data were imputed if over half of the data were missing for a
subscale. If less than or equal to half of the data were missing, items were replaced with
the subscale mean for that individual. Following this criterion, item-level data were
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replaced for six individuals for the PANAS. Four patients had missing one or two items
replaced. One patient had four missing data points replaced. One patient missed exactly
half of the PANAS items (equally split between PA and NA), thus the subscale means
were replaced for those ten missing items, and the patient was kept in the dataset. Four
individuals had item-level data missing for the CES-D; three patients had one missing
item, and one patient had two missing items. Two people did not complete the CES-D,
but these individuals were retained in the overall dataset (with no CES-D score) due to
small sample size; these individuals did not significantly differ from the overall dataset
on demographic or medical features. Missing data were imputed before total or sum
scores were calculated.
Cortisol. Salivary cortisol data was collected over ten days to maximize the
reliability of intended cortisol outcome variables (Segerstrom et al., 2014). The sampling
times of waking and bedtime were selected because they will allow calculation of the
diurnal cortisol slope (Sephton et al., 2000). Raw cortisol values were log-transformed
prior to analysis to account for known skew, and diurnal mean cortisol was calculated
using the log-transformed daytime values. Cortisol values were regressed on collection
time to yield a diurnal cortisol slope for each individual (Sephton et al., 2000; Sephton et
al., 2013). Final cortisol outcome variables consisted of mean log waking value, mean log
bedtime value, overall diurnal log mean, and diurnal slope calculations over the ten-day
collection period.

40

Statistical Analyses
Data reduction and scoring. Questionnaire data. Two research assistants
entered questionnaire data into independent databases. The databases were compared to
ensure correct entry. Questionnaires were scored after missing data were replaced.
Cortisol. Raw cortisol data consisted of an exact collection time recorded by
research subjects on saliva collection tubes and a laboratory-generated cortisol value
(µg/dl) from the assay. Collection times were recoded first to military time (i.e., 8:30 PM
becomes 20:30) and then transformed to numeric time (i.e., 20:30 becomes 20.5 hr).
Bedtime samples collected after midnight (e.g., bedtime sample collected at 12:30 AM)
were recoded as occurring beyond 24:00 hours (e.g., 12:30 AM coded as 24.5 hr, 1:15
AM coded as 25.25 hr, etc.). Assay results that were too high to be read by the standard
curve were diluted and re-assayed with subsequent results adjusted accordingly. Sample
collection times reported by subjects were checked and corrected using wrist-worn
actigraphy data, collected for aims of the parent study. Several baseline cortisol samples
(7.5%) had collection times that were modified based on one of the following reasons: 1)
to ensure records were cohesive in using the military time format, 2) to exclude samples
collected more than 15 minutes after actigraphy-based waking as the salivary waking
samples, as they instead reflect cortisol awakening response, 3) to correct collection time
of bedtime samples such that they were not listed as having been collected after
participants were asleep. Prior to calculating cortisol variables of interest, raw cortisol
values were transformed using the natural log to account for known positive skew.
Diurnal slope was calculated by regressing the log-transformed cortisol values
(waking, bedtime) on time (numeric, hours). A maximum of twenty total cortisol samples
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per participant were therefore be entered into the regression. The diurnal slope is
represented by the unstandardized beta from the regression. Values for the diurnal
cortisol slope are generally negative between 0.9 and -0.9 with higher numbers indicating
flattened or aberrant slopes. Mean raw and log-transformed cortisol values were
calculated by averaging all cortisol data points collected at waking and bedtime, both
together and separately.
Sample characteristics. Characteristics of the sample were determined by
calculating frequency, percentage, and mean data on demographic variables.
Descriptive statistics. Descriptive data in the form of means, standard deviations,
and percentages were calculated for independent and dependent variables.
Tests of hypotheses. Descriptive analyses were used to determine the fit of the
data with regard to all assumptions of analyses. All assumptions were met prior to
analysis, and significant outliers were removed if present. Statistical analyses for each
Aim are described below.
Aim 1. Hypothesis 1.1 was approached in an exploratory manner. Descriptive
statistics (mean, standard deviation, range, frequencies) were used to understand the
overall distribution of positive affect (PANAS items, CES-D positive items). A withinsubjects two-tailed t-test tested the hypothesis that patients would report more PA than
NA (PANAS subscales). To explore PA on the construct level, bivariate correlations
between the PA subscale of the PANAS and the PA items of the CES-D and between the
PA and NA subscales of the PANAS were conducted.
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Hypothesis 1.2 was examined through an exploratory factor analysis, in which it
was hypothesized that PA and NA items from the PANAS would fall into two distinct
factors in this lung cancer sample.
Hypothesis 1.3 assessed the relationship between PA and demographic/medical
features, hypothesizing that variables reflecting lower disease burden (e.g., lower stage,
no current treatment, longer time since diagnosis) would be associated with higher PA.
Bivariate correlations assessed the strength of the relationship between PANAS scores
(subscales, items) and CES-D scores (subscale, items) and demographic/medical factors.
Pearson r correlations were used for continuous, linear variables (e.g., age, time since
diagnosis); point-biserial procedure of Pearson r correlations was used for dichotomous
variables (e.g., gender). Data used in Pearson r correlations met assumptions of linearity
and normality prior to analyses. If assumptions were violated, Spearman rank correlations
were used. Spearman rank correlations were used for ordinal data (e.g., cancer stage).
Data used in Spearman correlations met the assumption of monotonicity. All correlations
used two two-tailed tests of significance.
Aim 2. For regression analyses of Aim 2 (Hypotheses 2.1 and 2.2), four
regressions were conducted for each of the four cortisol dependent variables. Primary
analyses utilized data-driven covariates; ad-hoc analyses utilized both data-driven and
theoretically-derived covariates. Across Hypotheses 2.1 and 2.2, the first regression
tested PANAS PA and data-driven covariates (Kraemer et al., 2001). The second
regression tested PANAS PA included both data-driven and theoretically-driven
covariates; theoretical covariates were decided based on previous literature (i.e., NA) and
lab conventions (i.e., corticosteroid use), but were limited in number due to small sample
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size. The third regression tested PANAS PA and CES-D with data-driven covariates
(Kraemer et al., 2001), and the fourth regression tested PANAS PA and CES-D with both
data-driven and theoretically-driven covariates.
Hypotheses 2.1 and 2.2 were analyzed using hierarchical linear regressions.
Regressions met assumptions of linearity, normality of residuals, and homoscedasticity
prior to analysis. In step one, theoretically and/or data-driven control variables (e.g., NA,
medical variables) were entered. In step two, the PA subscale was entered. For
Hypothesis 2.1, the outcome variables were log mean diurnal cortisol, log mean waking
cortisol, and log mean bedtime cortisol, respectively. For Hypothesis 2.2, the outcome
variable was diurnal cortisol slope.
Hypothesis 2.3 was explored using path analysis. The primary model included the
exogenous variables of PA (PANAS-PA) and endogenous variables of mean diurnal
cortisol and diurnal cortisol slope. All statistical assumptions were met prior to analysis.
Secondary exploratory models were constructed to assess the contribution of control
variables and CES-D PA, similar to the Hypotheses 1 and 2 regressions. The model
parameters were reviewed, and model fit was assessed. Adjustments to improve model fit
were addressed.
Power analysis. G*Power version 3.1.3 was used to determine the power of the
enrollment sample size (N = 61) for the study aims. Voogt et al. (2005) found a small to
medium effect of age (r = -.32) on PA in their sample of 105 mixed cancer patients.
There was a medium effect of gender (Cohen’s d = .48, women had higher PA) and small
effect of income (Cohen’s d = .19, higher income associated with more PA). The authors
found a small effect of medical variables: length of disease in months (r = .06), planned
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surgery (Cohen’s d = .87), planned chemotherapy (Cohen’s d = .06), planned radiation
(Cohen’s d = .36). Increased physical functioning was positively associated with PA (r =
.26). A small effect size of stage on PA (r = -.04) was found in a sample of 133 lung
cancer patients (Hirsch, Floyd, & Duberstein, 2012). Based on the expectation of a small
to medium effect size in our sample of 61, our power will range between .33 and .99 for
Aim 1.
Previous studies note a small to medium effect size for the relationship between
PA and cortisol. Polk et al. (2005) found small effect of .12 for the association of PA and
reduced waking cortisol concentration in their sample of 334 healthy adults. They also
noted a small effect of PA on diurnal slope (r = -.04 for trait PA, r = .10 for state PA;
Polk et al., 2005). Another study of 166 healthy adolescents showed a small but
significant effect of PA on steeper diurnal cortisol slope (β = -.04) and a significant
medium to large effect size on lower bedtime cortisol (β = -.661; Hoyt et al., 2015).
Miller et al. (2016) found a small but significant effect of PA on steeper diurnal cortisol
slope (β = -.19) in their sample of 490 healthy adults. In a breast cancer sample (N = 29),
Giese-Davis, DiMiceli et al. (2006) found a small to medium effect of .38 for the
association of PA expression and reduced mean cortisol. The authors found no effect of
PA expression on diurnal cortisol slope (r = -.01) but found a medium effect size on
lower 8:00AM cortisol (r = -.33; Giese-Davis, DiMiceli et al., 2006). Based on the
expectation of a small to medium effect size on cortisol measures in our sample of 61,
our expected power ranged between .19 and .85 for Aim 2.
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RESULTS
Patient Characteristics
Patient demographics are presented in Table 2. Medical variables of the patient
sample are presented in Table 3 (staging and diagnosis), Table 4 (medications), Table 5
(smoking history), and Table 6 (cancer treatment).
Aim 1
Hypothesis 1.1. Descriptive statistics were used to understand the overall
distribution of positive affect. Table 7 presents the descriptive statistics of the items and
summary scores for the PANAS and the positive items of the CES-D. Patients reported
moderate PA (PANAS: M = 28.79, SD = 8.57, range = 11 – 47). The distributions of the
PANAS PA subscale and the individual PA items appeared normal, with the exceptions
of “proud”, which was more uniform in distribution, and “inspired”, which had a slight
positive skew. On the PANAS, the most endorsed positive emotion was “Determined” (M
= 3.31, SD = 1.15), and the least endorsed positive emotion was “Inspired” (M = 2.59,
SD = 1.24). The CES-D PA subscale was negatively skewed, W(59) = .908, p < .001,
with most people reporting moderate to high levels of PA (M = 8.57, SD = 2.98, range =
1 – 12). The most common positive emotions endorsed on the CES-D were “I enjoyed
life” and “I felt just as good as other people” (M = 2.31), while the least endorsed item
was “I feel hopeful about the future” (M = 1.81). The distribution of PANAS PA and NA
item means is shown in Figure 3.
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A paired samples t-test tested the hypothesis that patients would report more PA
than NA. The PANAS NA subscale was positively skewed, W(61) = .923, p = .001, while
the PA subscale was normally distributed, W(61) = .985, p = .661; however, differences
between the scores were computed and checked for normality using the Shapiro-Wilk
test. The distribution of the differences between the PA and NA scores was normal,
W(61) = .988, df = 61, p = .828, thus no assumptions were violated. The Shapiro-Wilk
test of normality was used as it has higher power than the Kolmogorov-Smirnov test
(Ghasemi & Zahediasl, 2012). Results indicated that, on average, patients experienced
more PA (M = 28.79, SD = 8.57) than NA (M = 19.46, SD = 8.26), as measured by the
PANAS. This difference, 9.33, 95% CI [6.52, 12.14], was significant t(60) = 6.633, p <
.001, and represented a large effect, d = 1.12.
Bivariate correlations explored whether the PA subscale of the PANAS related to
the CES-D PA subscale. The PANAS PA subscale was positively correlated with
positive emotion (CES-D positive items, rs = .528, p < .001), which reflected a large
effect size (Cohen, 1992). Although PANAS PA and CES-D were significantly correlated
(thus risking multicollinearity), the CES-D was included in subsequent regression
analyses (Aim 2) given that the correlation was less than .80 (Fields, 2013, p. 325).1 The
PANAS PA and NA subscales were not significantly correlated (r = .138, p > .05).
Summary of hypothesis 1.1 results. Hypothesis 1.1 was supported. Patients
reported experiencing moderate levels of PA over the previous week. On average, they
endorsed experiencing significantly more PA than NA. The PA subscales of the PANAS
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CES-D was included in regression analyses also at the request of a committee reviewer
at the time of the proposal review.
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and CES-D were significantly correlated, providing construct validity. Last, the PA and
NA subscales of the PANAS were not correlated, in line with previous literature.
Hypothesis 1.2. Given the small sample size, the results of the EFA must be
interpreted with caution. Some data suggests that 10-15 participants per variable is most
reliable (Fields, 2012, p. 683); although, other research suggests a 3:1 participant-tovariable ratio may be adequate enough to detect underlying factors (Anderson & Rubin,
1956). Thus, with 61 participants and 20 variables (each of the 20 PANAS items), the
available data meets a minimum requirement for an EFA. Kaiser-Meyer-Olkin measure
of sampling adequacy (KMO) for this sample suggested an adequate and acceptable
sample size (KMO = .734). Furthermore, communalities prior to extraction ranged from
.556 - .856, again suggesting data were adequate to explore underlying factor structure.
An initial check of correlations between items was conducted to examine data for
extreme levels of multicollinearity (r > .8) and singularity (r = 1). No correlation
exceeded r = .8. The highest item correlations were between active and determined (r =
.742, p < .001) and scared and afraid (r = .757, p < .001). Bartlett’s test confirmed that
the correlation matrix contained acceptable levels of correlations between variables (χ2
(190) = 761.605, p < .001). All 20 PANAS items were therefore used in the EFA. Output
was sorted by loading size, and factor loadings were not suppressed by loading size.
EFA was conducted using Principal Axis Factoring. The first extraction was
based on Kaiser’s rule and eigenvalues greater than 1. Since missing data had already
been imputed and given the small sample size, pairwise case exclusion was selected to
minimize any loss of data. Although theoretical and objective data from this sample
suggest that PA and NA are independent and distinct dimensions, an oblique rotation
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using promax criterion was conducted due to the exploratory nature of this analysis
(Costello & Osborne, 2005). Oblique rotation allows for the potential for underlying
factors to be correlated or uncorrelated, whatever best fits the data. Thus, if the
underlying factors were indeed uncorrelated in this sample, a largely orthogonal solution
would nevertheless emerge, despite using an oblique rotation method.
Using the eigenvalue greater than 1 criterion, the EFA extracted five factors. Of
variance accounted for by these factors, factors 1 and 2 explained the most (29.8% and
23.1%, respectively), while factors 3 through 5 explained much less (8.0%, 5.9%, 5.6%,
respectively). The scree plot (Figure 4) demonstrated points of inflexion at the third,
fourth, and sixth factors, suggesting a two, three, or five factor solution may be most
appropriate for the data. These three solutions were therefore explored more thoroughly
by re-running the analyses with forced cut-off criteria of two, three, and five factor
solutions.
Two-factor solution. In the two-factor solution, all 20 PANAS items fell into the
same PA and NA subscales as identified on the standardized measure. The pattern matrix
(Table 8) revealed PA items strongly loaded onto factor 2 (coefficients ranged from .441
- .816) and not factor 1 (coefficients ranged from -.230 - .152), while NA items strongly
loaded onto factor 1 (coefficients ranged from .326 - .827) and not factor 2 (coefficients
ranged from -.184 - .148). Consistent with previous bivariate correlations, the
intercorrelation matrix indicated that these PA and NA factors were mildly positively
correlated (r = .12). The factor plot demonstrates that all PA and NA items strongly load
onto two factors representing the respective PA and NA subscales of the PANAS (Figure
5).
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Three-factor solution. In the three-factor solution, all 10 PA items remained a
cohesive factor, with coefficients ranging from .422 to .802. The PA items with the
highest coefficients (>.7) were strong, proud, inspired, determined, attentive, and active.
The pattern matrix (Table 9) showed that the NA items fell into two factors, with shame
and guilt emotions emerging as a separate factor from the other items (factor 3;
coefficients of .873 and .694). These two factors were moderately positively correlated (r
= .336). The PA factor remained mildly correlated with the NA factor (r = .113) and the
shame/guilt factor (r = .135). The three-dimensional factor plot provides a visual
representation of the three-factor solution (Figure 6).
Five-factor solution. In the five-factor solution, the pattern matrix (Table 10)
showed that items most strongly loaded onto the first four factors, suggesting the five
factor solution is least parsimonious. In this solution, PA items fell into two factors, with
excited and enthusiastic emerging as a separate factor (factor 4; coefficients of .682 and
.583). The other PA items remained loaded together (factor 2; coefficients ranged from
.358 - .866). The PA items with the highest coefficients (>.7) were determined, attentive,
active, and strong. The NA items remained divided into two factors of general NA (factor
1; coefficients ranged from .606 to .882) and shame/guilt (factor 3; coefficients of .647
and .927). The PA factors were moderately correlated to each other (r = .502), but were
uncorrelated to the other factors (all r’s < .10).
Summary of hypothesis 1.2 factor analysis. Overall, the factor analysis remained
consistent with previous literature that indicates that PA and NA are separate and distinct
constructs. Using oblique rotation, the PA items consistently grouped together and
remained uncorrelated to NA items. The two-factor solution explained the large majority

50

of the variance of the model and aligned exactly with the previously validated PA and
NA subscales of the PANAS measure. The three-factor solution suggested that feelings
of shame and guilt may be uniquely experienced in a lung cancer sample, separate from
other negative emotions. Similarly, based on the five-factor solution, feelings of
excitement and enthusiasm may be experienced differently than other positive emotions
among lung cancer patients.
Hypothesis 1.3. Associations with the PANAS. Associations with higher positive
affect were explored through correlations with demographic, diagnosis and staging,
smoking history, and treatment variables. Positive affect was significantly correlated with
race (rs = -.265, p = .039), such that African American patients endorsed higher positive
affect than White patients. Positive affect was not correlated with gender, years of
education, or income.
PA was not correlated with diagnosis and staging variables (age at diagnosis, time
since diagnosis, stage, whether they had a comorbid medical condition). Positive affect
was not correlated to current medications. Of the smoking history variables, PA was
negatively correlated to years smoking (the longer the patient smoked, the less PA; r = .296, p = .028).
Of the cancer treatment variables, PA was correlated with current chemotherapy
treatment, such that patients endorsed less PA if they were currently in treatment (rs = .374, p = .004). Similarly, having received chemotherapy in the past two months was
correlated with lower PA, but at a trend level (rs = -.246, p = .068). Positive affect was
not correlated to overall endorsement of ever receiving chemotherapy or with any
radiation therapy variables.
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Overall, some support for hypothesis 1.3 was found with the PANAS. Some
variables indicating higher disease burden (longer smoking history, current or recent
chemotherapy) were related to lower PA. Patients who endorsed significantly lower PA
were White patients, those with a long history of smoking, and those who were currently
receiving chemotherapy. African American patients, those who had smoked for fewer
years, and those who were not currently in chemotherapy endorsed higher PA.
Post-hoc analyses explored which PA items were potential drivers of the
significant correlations observed with the PA subscale as a whole. Six PA items were
significantly related to race: strong (rs = -.423, p = .001), attentive (rs = -.395, p = .002),
determined (rs = -.368, p = .004), active (rs = -.356, p = .005), inspired (rs = -.315, p =
.013), and interested (rs = -.238, p = .037). Three PA items were significantly related to
number of years smoking: active (r = -.377, p = .005), alert (r = -.303, p = .024), and
determined (r = -.293, p = .030). Six PA items were significantly related to current
chemotherapy status: enthusiastic (rs = -.351, p = .006), inspired (rs = -.346, p = .007),
strong (rs = -.334, p = .010), determined (rs = -.320, p = .013), interested (rs = -.313, p =
.016), and active (rs = -.307, p = .018).
Associations with CES-D PA. The CES-D PA subscale showed a mostly similar
pattern, with a few key differences. Again, race was associated with PA, with African
Americans endorsing higher PA (rs = -.227, p = .033). Post-hoc item level analysis
showed that race was significantly correlated (in the same direction) with two items:
feeling just as good as other people (rs = -.295, p = .023) and enjoying life (rs = -.358, p =
.005). Gender, education, and income were not associated with CES-D PA.
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Again, CES-D PA was not correlated with diagnosis and staging variables (age at
diagnosis, time since diagnosis, stage, whether they had a comorbid medical condition).
However, while no medications were associated with PANAS PA, use of
benzodiazepines (rs = -.282, p = .030) and use of estrogen medications (rs = -.256, p =
.050) were associated with lower CES-D PA. Post-hoc item level analysis revealed that
benzodiazepine use was negatively related to three of the four items: feeling hopeful
about the future (rs = -.284, p = .029), feeling happy (rs = -.333, p = .010), and enjoying
life (rs = -.320, p = .013).
Correlations between PA and smoking variables differed between the PANAS-PA
and CES-D PA. Of the smoking history variables, CES-D PA was negatively correlated
with current number of packs/week (r = -.604, p = .029) and cigarettes/day (r = -.606, p =
.022), but not with number of years the patient smoked as with the PANAS-PA. Post-hoc
item level analysis revealed that items of ‘feeling happy’ and ‘enjoying life’ were related
to currently smoking fewer packs per week (happy: r = -.637, p = .019; enjoying life: r =
-.817, p = .001) and fewer cigarettes per day (happy: r = -.585, p = .028; enjoying life: r =
-.750, p = .002). Lower number of current cigarettes per day was also correlated with
“feeling just as good as other people” (r = -.563, p = .035). Other smoking variables were
not significantly correlated to PA.
Similar to the PANAS PA, patients who were currently in chemotherapy (rs = .412, p = .001) or had chemotherapy in the past two months (rs = -.386, p = .004) had less
PA on the CES-D. Post-hoc item level analysis revealed that patients who were currently
in chemotherapy or had chemotherapy in the past two months reported less hopefulness
about the future (current: rs = -.343, p = .008; past two months: rs = -.307, p = .023) and
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enjoying life less (current: rs = -.497, p < .001; past two months: rs = -.358, p = .007).
CES-D PA was not correlated to overall endorsement of ever receiving chemotherapy or
with any radiation therapy variables.
Overall, some support for hypothesis 1.3 was again found with the CES-D.
Higher PA was experienced among African American patients and those not currently or
recently in chemotherapy treatment. In particular, current or recent chemotherapy
treatment was correlated with less hopefulness and less enjoyment of life. Positive affect
was also associated with smoking variables, but captured different aspects than the
PANAS. Current smoking behaviors, not years of overall smoking, were related to PA.
Patients smoking less (packs/week, cigarettes/day) reported higher PA, and in particular
endorsed being happier and enjoying life more. The CES-D PA also appeared to relate to
medication use, while the PANAS PA did not. Patients not taking benzodiazepines or
estrogen medication reported higher PA on the CES-D.
Summary of hypothesis 1.3 results. Associations with the PANAS and CES-D
both showed that African American race and not currently being treated with
chemotherapy predicted higher PA. Nuances in the relationship between PA and
medications and smoking history emerged between the two measures. Use of
benzodiazepine and estrogen were associated with lower CES-D PA, but were not related
to PANAS PA. Patients who smoked less (historically, as captured by PANAS PA, or
currently, as captured by CES-D) endorsed higher PA. Taken together, higher PA seems
to be associated with African American race, no current chemotherapy treatment, and
smoking less.
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Aim 2
Data-driven covariates of cortisol outcomes. A description of cortisol variables
is presented in Table 11. Correlation analyses tested significance of potential covariates
of cortisol variables to be selected for use in analyses of Aim 2 hypotheses. Potential
covariates included gender, race, age of diagnosis, stage, years of education, income, time
since diagnosis, total pack years, current corticosteroid use, and current chemotherapy.
Raw mean waking cortisol had no significant correlates. Raw mean bedtime cortisol was
correlated at a trend level with whether the patient was currently receiving chemotherapy
treatment (rs = .248, p = .068). Log mean waking cortisol did not significantly correlate
with any variables. Log mean bedtime cortisol significantly correlated with age at
diagnosis (r = .322, p = .014) and number of years smoking (r = .299, p = .033). Log
mean diurnal cortisol correlated at the trend level with stage (rs = .241, p = .071). Cortisol
slope was not significantly correlated with any covariates. Only the significant correlates
for each cortisol outcome were used as control variables (covariates) in data-driven
models for hypotheses 2.1 and 2.2. Thus no data-driven covariates were used for
regressions with log mean diurnal cortisol, log mean waking cortisol, or cortisol slope.
Data-driven covariates were only used for log mean bedtime cortisol regressions (i.e., age
at diagnosis and number of years smoking) (Kraemer et al., 2001).
All independent variables were centered prior to regression analysis (Kraemer &
Blasey, 2004). Continuous variables were centered to their median. Dichotomous
independent variables were coded as −1/2 and +1/2. Ordinal variables were coded as
deviations around their median values, and categorical variables with m response options
were dummy coded into −1/m and 1–1/m (e.g., −0.25 and 0.75) instead of 0 and 1.
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For each regression conducted, the data were first explored for violations of
assumptions of linearity, homoscedasticity, normal distribution of residuals, and absence
of collinearity. Among all variables, no significant outliers were noted or removed, and
relationships were deemed to be linear. Assumptions of linearity and normal distribution
of residuals were met for all regressions. In all regressions, missing cases were removed
pairwise to maintain power.
Hypothesis 2.1. Mean Diurnal Cortisol. Hierarchical linear regressions tested the
association between PA and mean diurnal cortisol. The first regression analysis did not
necessitate any data-driven covariates and revealed that PANAS-PA was not associated
with mean diurnal cortisol (p > .05; Table 12).
A second regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA and corticosteroid use) and PANAS-PA (Step 2; Table 13). Corticosteroid
use was significantly associated with mean diurnal cortisol (p = .043); PANAS-NA and
PANAS-PA were non-significant (p > .05).
A third regression analysis tested the association of both PANAS-PA and CES-D
PA (no covariates) with mean diurnal cortisol also revealed no significant associations (p
> .05; Table 14).
A final regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA,
CES-D PA; Table 15). Corticosteroid use was associated with mean diurnal cortisol at a
trend level (p = .062); no other covariates or independent variables were significantly
associated with mean diurnal cortisol (p > .05).
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Waking Cortisol. Hierarchical linear regressions tested the association between
PA and mean waking cortisol. The first regression analysis did not necessitate any datadriven covariates and revealed that PANAS-PA was not associated with mean waking
cortisol (p > .05; Table 16).
A second regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA and corticosteroid use) and PANAS-PA (Step 2; Table 17). Corticosteroid
was significantly associated with waking cortisol (p = .020); PANAS-NA and PANASPA were non-significant (p > .05).
A third regression analysis tested the association of both PANAS-PA and CES-D
PA (no covariates) with mean waking cortisol. The analysis revealed that higher CES-D
PA was associated with lower mean waking cortisol at a trend level (β = -.292, p = .053),
while PANAS-PA was not associated with waking cortisol (p > .05; Table 18).).
A final regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA,
CES-D PA; Table 19). Corticosteroid use was associated with mean waking cortisol (β =
-.295, p = .030), and CES-D PA significance fell to a trend-level (β = -.269, p = .080). No
other covariates or independent variables were significantly associated with mean waking
cortisol.
Bedtime Cortisol. Hierarchical linear regressions tested the association between
PA and mean bedtime cortisol. The first regression analysis included data-driven
covariates (Step 1; age at diagnosis, years smoking) and PANAS-PA (Step 2) and
revealed that no variables were significantly associated with mean bedtime cortisol (p’s >
.05; Table 20).
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A second regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use), data-driven covariates (Step 1; age at diagnosis, years
smoking) and the PANAS-PA (Step 2; Table 21). Corticosteroid was significantly
associated with mean bedtime cortisol (p = .020); PANAS-NA and PANAS-PA were
non-significant (p > .05).
A third regression analysis testing the association of data-driven covariates (Step
1; age of diagnosis, years smoking) and both PANAS-PA and CES-D PA (Step 2) with
mean bedtime cortisol again revealed that no variables were significantly associated with
mean bedtime cortisol (p > .05; Table 22).
A final regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use), data-driven covariates (Step 1; age at diagnosis, years
smoking), and PA independent variables (Step 2; PANAS-PA, CES-D PA; Table 23).
Again, no variables were significantly associated with mean bedtime cortisol and no
models were significant overall (p’s > .05).
Hypothesis 2.2. Diurnal Cortisol Slope. Hierarchical linear regressions tested the
association between PA and diurnal slope. The first regression analysis did not
necessitate any data-driven covariates and revealed that PA was not significantly
associated with diurnal slope (p > .05; Table 24).
A second regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use) and the PANAS-PA (Step 2; Table 25). All variables
were non-significant (p > .05).
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A third regression analysis testing the association of both PANAS-PA and CES-D
PA (Step 1) with diurnal slope again revealed that no variables were significantly
associated with slope (p > .05; Table 26).
A final regression analysis included theoretically-driven covariates (Step 1;
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA,
CES-D PA; Table 27). Again, no variables were significantly associated with cortisol
slope and no models were significant overall (p’s > .05).
Post-hoc analyses: Exclusion of patients on corticosteroids. To check that
inclusion of patients on corticosteroids did not bias regression outcomes, patients
currently on corticosteroid regimen (n = 20) were excluded from the dataset. Correlations
of demographic and medical variables with cortisol outcomes were repeated to assess for
potential covariates again; no significant covariates of cortisol outcomes were identified.
Thus, regressions were conducted first with no covariates. A second regression adjusted
for NA. A third regression included CES-D PA with no covariates. A final regression
included NA, as well as CES-D PA.
In line with findings from the full dataset, PA (PANAS or CES-D) was not
significantly associated with overall diurnal cortisol, mean log waking cortisol, mean log
bedtime cortisol, or diurnal slope in any model (all p’s > 0.5). PANAS-NA was also not
significantly associated with overall diurnal cortisol, mean log waking cortisol, or mean
log bedtime cortisol (all p’s > .05). One difference did emerge however: PANAS-NA was
associated with diurnal slope at a trend level the model that included PANAS-PA (Table
28), and this association became statistically significant in the model with both PANASPA and CES-D PA (Table 29). In these models, having more NA was associated with
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having a flatter (i.e., more disrupted) diurnal slope (Figure 14); however, the overall
model remained non-significant.
Hypothesis 2.3. Data were prepared in order to meet all statistical assumptions
prior to path analysis. Centered data were used for exogenous (predictor) variables in
order to remain consistent with the multiple regressions previously conducted. First,
patients who did not have cortisol outcome data were excluded from the analysis (n = 4)
in order to meet the criterion of having no missing data. Second, two participants had not
completed the CES-D PA, thus their total scores were missing; however, they were not
missing any other data points. Therefore, the overall mean CES-D PA value from the
sample (then centered to the median) was imputed for these two data points.
Path analyses were performed using Amos version 25. An initial path analysis
was used to evaluate the hypothesized model that PA would more strongly relate to
overall diurnal mean than to diurnal cortisol slope. The purpose of this model was to
compare the path coefficients (beta weights) between PA and mean diurnal cortisol as
well as PA and diurnal cortisol slope in one simultaneous model. The primary hypothesis
was that the relationship between positive affect and mean diurnal cortisol would be
greater (higher absolute value of path coefficient) than the relationship between positive
affect and diurnal cortisol slope. Standardized regression weights (β) are reported. In line
with previous regression model hypotheses, it was expected that positive affect would be
negatively associated with mean diurnal cortisol and positively associated with diurnal
slope.
Model 1. Model 1 is a path diagram of the predicted interrelationships between
the basic variables of the hypothesized model (Model 1; Figure 7): the exogenous
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variable was PANAS PA; the endogenous variables were mean diurnal cortisol and
diurnal cortisol slope. Error terms were derived from the endogenous variables. Path
analysis demonstrated that PA was not significantly associated with cortisol variables
(mean diurnal cortisol: β = -.088, p = .507), diurnal cortisol slope: β = .080, p = .549).
The error terms of the cortisol variables were not significantly correlated (r = -.19, p =
.163).
Fit indices of Model 1 were reviewed to assess the match between the model and
the data. When the error terms of the cortisol variables were free to correlate, the Chi
Square statistic had zero degrees of freedom (χ2 = .000, df = 0), thus the probability level
could not be computed and model fit could not be assessed. However, when the error
terms were fixed as uncorrelated, the Chi Square statistic showed a non-significant
difference between the predicted covariance matrix and the actual covariance matrix
(CMIN = 2.049, df = 1, CMIN/df = 2.049, p = .152). Yet, the model demonstrated overall
poor fit to the data (CFI = .000; IFI = .432; RMSEA = .137; NFI = .280). No
modification indices were suggested in order to improve model fit.
This first model’s poor fit to the data and the non-significant p-values of the paths
do not lend full support for the hypothesis. However, the hypothesis may be partially
supported in that the absolute value of the beta weight for the association between PA
and mean diurnal cortisol was indeed greater than that of the cortisol slope. Further, the
beta weight was in the hypothesized direction for overall mean cortisol.. Therefore,
although the paths did not reach significance, the findings may suggest that this model is
underpowered.
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Model 2. An exploratory second model with more observed variables was
constructed, based on the previous multiple regression analyses (Model 2; Figure 8).
Secondary predictive variables (control variables) were included in the model given the
theory-driven relationships previously established: corticosteroid use and PANAS
negative affect. It was hypothesized that corticosteroid use will be associated with both
cortisol variables. It was hypothesized that negative affect will be associated with higher
mean cortisol and disrupted (i.e., flattened, lower) slope values. Overall model fit and
hypothesized associations within Model 2 were reviewed.
Model 2 exogenous variables included positive affect (PANAS), negative affect,
and corticosteroid use; endogenous variables were mean diurnal cortisol and diurnal
cortisol slope. Error terms were derived from the endogenous variables. Path analysis
demonstrated that PA was not significantly associated with cortisol variables (mean
diurnal cortisol: β = -0.141, p = .268; diurnal cortisol slope: β = 0.081, p = .533).
Negative affect was also not significantly associated with cortisol variables (mean diurnal
cortisol: β = 0.071, p = .576; diurnal cortisol slope: β = 0.150, p = .247). Corticosteroid
use was associated with lower overall cortisol mean (β = -0.274, p = .030), but not with
diurnal slope (β = 0.165, p = .203).
Fit indices of Model 2 were reviewed to assess the match between the model and
data; the model demonstrated good fit to the data. The Chi Square statistic showed a nonsignificant difference between the predicted covariance matrix and the actual covariance
matrix (CMIN = 3.042, df = 3, CMIN/df = 1.014, p = .385). Other indicators also
supported good model fit (CFI = .986; IFI = .996; RMSEA = .016), while one index
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suggested less of a fit (NFI = .764). No modification indices were suggested in order to
improve model fit.
The absolute value of the beta weight for the association between PA and mean
diurnal cortisol was again indeed greater than that of the cortisol slope in this model.
Several associations were in the predicted directions: higher PA and lower NA were
related to a pattern of lower mean cortisol. All other variables seemed to be associated
with flattened slopes; although, NA and corticosteroid use seemed to be more strongly
suggestive of flatter slopes than PA. The non-significance coupled with the near-zero
beta weights prevents us from drawing any firm conclusions regarding PA’s relative
associations to the cortisol variables. Thus, the hypothesis could not be firmly supported.
However, the model did demonstrate better fit to the data than Model 1 and the beta
weight from PA to mean cortisol increased strength from Model 1.
Model 3. An exploratory third model was created to consider the relationship
between CES-D PA and cortisol outcomes (Model 3; Figure 9). In line with previous
regressions, this model included PANAS PA and NA, CES-D PA, and corticosteroid use
as the exogenous variables, while mean diurnal cortisol and diurnal cortisol slope
remained the endogenous variables. Overall model fit and hypothesized associations
within Model 3 were reviewed.
Path estimates were similar to those of Model 2. Path analysis demonstrated that
PANAS PA was not significantly associated with cortisol variables (mean diurnal
cortisol: β = -0.046, p = .718; diurnal cortisol slope: β = -0.013, p = .916). CES-D PA
was also not significantly associated with cortisol variables (mean diurnal cortisol: β = 0.192, p = .128; diurnal cortisol slope: β = 0.187, p = .142). Negative affect was also not
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significantly associated with cortisol variables (mean diurnal cortisol: β = 0.030, p =
.812; diurnal cortisol slope: β = 0.190, p = .136). Corticosteroid use was associated with
lower overall cortisol mean (β = -0.252, p = .046), but not with diurnal slope (β = 0.139,
p = .275).
Fit indices of Model 3 were reviewed to assess the match between the model and
data; the model demonstrated poor fit to the data. The Chi Square statistic showed
significant difference between the predicted covariance matrix and the actual covariance
matrix (CMIN = 19.866, df = 6, CMIN/df = 3.311, p = .003). Other indicators also
suggested poor model fit (CFI = .210; IFI = .478; NFI = .390; RMSEA = .203).
Modification indices suggested correlating PANAS PA and CES-D PA (MI = 11.205, Par
Change = 10.672) as a way to improve model fit.
When this modification was completed, the model demonstrated better fit to the
data. The PANAS PA and CES-D PA were moderately, but significantly correlated (r =
.447, p = .002). The Chi Square statistic showed a non-significant difference between the
predicted covariance matrix and the actual covariance matrix (CMIN = 7.363, df = 5,
CMIN/df = 1.473, p = .195). Other indicators also suggested improved model fit (CFI =
.865; IFI = .914; NFI = .774; RMSEA = .092). No modification indices were suggested in
order to improve model fit.
In again partial support of the hypothesis, the absolute value of the beta weight for
the association between PANAS-PA and mean diurnal cortisol was indeed greater than
that of the cortisol slope. Higher PA (CES-D and PANAS-PA) and lower NA seemed to
be related to lower mean diurnal cortisol. All other variables seemed to be associated
with flattened slopes. As previously noted however, the non-significance of the beta
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weights prevents us from drawing any significant conclusions regarding PA’s relative
associations to the cortisol variables. The model including CES-D PA did not
demonstrate as good of a fit as the Model 2. As expected, correlating PANAS-PA and
CES-D PA, improved model fit however.
Summary. Hypotheses and overall findings (whether each hypothesis was
supported) are presented in Table 30. PA seemed to have a stronger relationship to mean
diurnal cortisol than to diurnal slope. Further, higher PA and lower NA seemed to be
related to lower mean cortisol. Most variables seemed to be associated with flattened
slopes, likely due to pre-existed cortisol dysregulation. Findings must be interpreted
cautiously, given the overall lack of statistical significance.
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DISCUSSION
This dissertation explored the experience of positive affect, and its biological
correlates, in a sample of non-small cell lung cancer patients. The importance of
understanding the emotional experiences of these patients cannot be underestimated.
Indeed, cancer diagnosis and treatment may be met with sadness, grief, and anxiety.
However, experiences of positive emotions and their underlying psychological processes
must be better understood to capture the full authentic emotional experiences of lung
cancer patients. This topic is drastically understudied in the current literature. Thus, the
results of this study highlight the nature of positive emotions as well as the potential
relationships to physiological pathways associated with a known prognostic feature
among lung cancer patients – cortisol dysregulation.
Capturing a snapshot of lung cancer patients served among the greater Louisville
area, the patients of the current study were mostly female, White, in their late 50s to early
60s, and had a high school education. Most patients (57.5%) had a household income of
under $40K per year. The majority of these patients had an initial diagnosis of stage III or
stage IV lung cancer and had been diagnosed about two years previously. Patients
diagnosed with this stage and type of cancer typically have had poor prognosis; patients
with stage III have a 5-year survival rate of 13-36%, while patients with IV have a 5-year
survival rate of <1-10% (American Cancer Society, 2017). As a somber representative of
this poor prognosis, several patients passed away during the duration of this study. As
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such, the patients in this current study were undergoing unique set of psychological and
physiological stressors as they faced a potentially terminal illness. However, as
highlighted in this work, the majority of these reported positive mood states, even more
so than negative mood. In honoring the complexity of emotional experiences when facing
lung cancer, this dissertation deeply explores the quality and correlates of these positive
emotions, while delving into the science behind the mind-body interaction of positive
affect and psychophysiology.
Aim 1 Discussion: Experiencing Positive Affect
Hypothesis 1.1. Aim 1 of the current study sought to understand the frequency
and quality of PA among lung cancer patients. By exploring elements of the person (e.g.,
demographic variables) and his or her cancer journey (e.g., medical variables), this aim
helped to capture the patient experience of PA on an item, subscale, and construct level.
Hypothesis 1.1 proposed that patients would experience moderate PA and would report
more PA than NA, as tested by the PANAS. Hypothesis 1.1 was supported.
Patients experienced moderate levels (scoring around 3 on a scale of 1-5) of PA.
This finding highlights that patients did, in fact, experience PA while facing their cancer.
As will be explored later, not only did the patients endorse actually experiencing positive
mood, they reported having more positive than negative emotions over the past week in
general. This endorsement of PA aligns with previous literature noting that, on average,
most people endorse feeling neutral to positive emotions, rather than negative emotions
(Diener & Diener, 1996). The experience of PA among cancer patients is also not
uncommon (Louro et al., 2015) and is the reason why it deserved scientific attention.
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The consistency of this pattern among this sample highlights a potential normative
experience of emotions overall, even in the face of cancer.
A closer look at the most highly endorsed individual positive emotions revealed
an interesting representation of the positive emotional states of these lung cancer patients,
and captured a theme of overall resilience. On the PANAS, the most endorsed positive
emotion was determined. In lung cancer patients, this may reflect psychological
resilience and active approaches to coping and overcoming their cancer diagnosis. In
other words, determined may reveal a “fighting spirit” coping strategy of these cancer
patients, which reflects a tendency to actively confront and face cancer (Watson et al.,
1994). In a study of 102 cancer patients, path analysis demonstrated that a fighting spirit
was significantly associated with positive affect and was a partial mediator between
optimism and positive emotions (Hodges & Winstanley, 2012). Determination in this
sample may be revealed in the medical context as the patient being motivated to adhere to
treatment, attend scheduled appointments, and even participate in this current research.
(The latter of which may also reflect a potential sample bias.) In a psychological context,
these patients’ determination may reflect a desire to live a full and meaningful life given
the diagnosis of a potentially terminal illness. Determination may be a product or proxy
of underlying resilient processes such as emotional flexibility, benefit finding, and posttraumatic growth. More research is needed to elucidate the underlying processes
contributing to this most commonly endorsed positive emotion in this sample. As such,
further analyses using the fighting spirit subscale of the Mini-MAC (Mini Mental
Adjustment to Cancer Scale; Watson et al., 1994) may elucidate the presence and extent
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of fighting spirit and its association with other positive psychological processes in this
sample.
The other most highly endorsed PA items were alert and interested (Figure 3).
Together, these three top PA items (determined, alert, interested) paint the picture of an
engaged and resilient cancer patient. Again, in the medical context, someone with these
features may be determined to fight his or her cancer by being alert and interested in the
recommendations and treatment planning of his or her oncology team. Outside the
medical setting, these three emotions may reflect a person who is present and engaged in
their current life, by showing interest and alertness to meaningful activities and a
determination to live life in a meaningful way in the face of a terminal illness.
On the CES-D, the highest rated positive items were “I enjoyed life” and “I felt
just as good as other people.” These again seem to reflect a sense of resilience: that these
patients are still enjoying life and have maintained a sense of esteem despite lung cancer.
This finding of feeling “just as good as other people” is interesting given the common
experience of shame and self-blame associated with smoking among lung cancer patients
(Else-Quest et al., 2009; LoConte et al., 2008). This is especially interesting as the
current sample was made up of almost entirely patients who had a history of smoking or
currently smoke. Of course, it is difficult to know how these patients understood and
interpreted the term “good”. It may be that these patients engaged in cognitive flexibility
about how to enjoy life despite their physical and emotional symptoms, which in turn led
them to feel just as good as others without medical conditions. Conversely, given the high
frequency of smoking in Kentucky, perhaps patients were comparing themselves to their
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peers or family members, who also smoke, thus removing much of the stigma and
allowing them to find commonality among other people.
The least endorsed positive emotion on the PANAS was inspired. Inspiration
denotes creating something new or having the urge to do or feel something. After a
diagnosis of lung cancer, these patients may not be feeling inspired to make large
changes in life (start new projects, etc.), but rather to enjoy what they have already.
Consistent with this, the least endorsed positive emotion on the CES-D was feeling
hopeful about the future. Again, these patients are facing a sobering reality of the poor
prognosis of lung cancer. Therefore the lack of inspiration and hope may not necessarily
be pessimism, but rather, realism.
PA vs. NA. Patients reported experiencing more overall PA than NA, and there
was a large effect size. This finding is similar to other previous research indicating that
cancer patients do indeed tend to report more PA than NA (Louro et al., 2015). Among
lung cancer patients, this finding may be surprising given that these patients also tend to
endorse more distress than other cancer samples (Brintzenhofe-Szoc et al., 2009; Linden
et al., 2012; Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001). However,
it appears that the current set of patients is also experiencing normative, and high, levels
of positive emotions, as seen in other cancer samples (Louro et al., 2015).
On the other hand, one may also consider that this finding could reflect the
tendency for people to avoid experiencing negative emotions – either by actively pushing
them away or denying their presence in general – or to judge themselves for feeling
negative emotions (David, 2017; Hayes, Strosahl, & Wilson, 2012). The endorsement of
PA and relative lack of NA in the sample may be a reflection of either false positivity,
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false non-negativity, or perhaps both. While we cannot say for certain whether the
patients are engaging in active denial of negative emotions and/or falsely inflating their
perception of their own positive mood states, it remains important to take this human
tendency into consideration while interpreting the results of the study.
As expected, the PA measures (PANAS-PA and CES-D PA) were positively
correlated, which also reflected a strong effect size. Their strong correlation offers
convergent construct validity for positive affect in this sample. Similarly, as seen in other
samples, the PA and NA subscales of the PANAS were not correlated, offering
discriminant validity to the measure. As suggested by previous studies, the current data
again suggests that PA and NA are two distinct constructs (e.g., Watson, Clark, &
Tellegen, 1988). With both convergent and discriminant validity of the PANAS PA, it
can be assumed that this measure is indeed capturing what we hoped to explore in the
current study – the experience of positive emotions.
Hypothesis 1.2. The second hypothesis of Aim 1 proposed that positive and
negative affect items will emerge as separate factors in an exploratory factor analysis.
Hypothesis 1.2 was supported. The factor analysis most strongly suggested a twofactor solution (Figure 4); although, three and five factor solutions also warrant attention.
In the two-factor solution, the PA and NA factors emerged separately in the factor
analysis, again indicting that they are separate and unique constructs. The two-factor
solution demonstrated that the items fell into the respective PA and NA subscales of the
standardized measure, offering support that the measure is valid among a sample of lung
cancer patients.
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Interestingly, in the three-factor solution, shame and guilt separated out from the
NA subscale, suggesting that these two negative emotions may be experienced differently
in the lung cancer sample. Among lung cancer patients, the experience of shame and guilt
often relates to smoking history and the stigma associated with lung cancer (Else-Quest et
al., 2009; LoConte et al., 2008). The finding that these two emotions emerged separately
in this sample seems to highlight the uniqueness of these emotions among lung cancer
patients. Given that all but two patients in the sample were either past or current smokers,
it is likely that smoking history may relate to the separation of shame/guilt from other
negative emotions in this sample. Future analyses may explore the unique contribution of
these negative emotions in psychophysiological pathways.
In the five-factor solution, excitement and enthusiasm separated out from the other
positive emotions. Compared to the other positive affect items on the PANAS, these two
emotions reflect a more active valence, which may not well suited to the diagnosis (i.e.,
functional ability). The other positive items (i.e., strong, determined, attentive,
interested, etc.) seem to fit better with a mindset of facing cancer as they may reflect a
slightly less active valence.
Overall, the factor analysis validated that PA and NA exist as separate constructs
in this sample. Further, a lack of negative emotion does not necessarily indicate a
presence of positive emotion, and vice versa. Instead, these emotions may exist together
in a dialectical relationship within the patient; distress and positive emotions can exist
together (Folkman & Moskowitz, 2000). That is, the patient may be scared and nervous,
but also feels strength and determination. As such, controlling for the effects of NA in the
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subsequent regression analyses remained an appropriate method for elucidating the
relative contributions of these separate emotional experiences.
Hypothesis 1.3. The third hypothesis of Aim 1 explored what demographics
would be associated with higher PA and specifically proposed that lower disease burden
(e.g., lower stage, no current treatment, longer time since diagnosis) would be associated
with higher PA. Hypothesis 1.3 was partially supported.
In considering demographic variables, African Americans endorsed more PA than
White patients. Among seminal happiness studies, research shows that African
Americans and European Americans typically endorse nearly the same levels of overall
happiness and life satisfaction (Myers & Diener, 1995). Thus in this sample, a unique set
of resilience factors may have contributed to this difference between races. Interestingly,
a closer look at the PA items revealed that “strong” was most significantly correlated
with race (i.e., African Americans endorsing “strong” more so than White patients).
Research suggests that African Americans endorse more meaning/peace and faith when
facing a chronic illness (including cancer), when compared to White or Latino
counterparts (Peterman et al., 2002). African American breast cancer patients also report
utilizing religious coping more so than non-Hispanic White patients (Culver et al., 2002).
Other unique coping strategies of African American cancer patients include developing a
positive attitude and avoiding negative people, having a will to live, and receiving a
variety of social support (Henderson et al., 2003). Therefore, there are unique cultural
factors to be further explored about the meaning of “strength” and its multidimensional
qualities in the context of cancer. In this sample, strength may be differentially
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interpreted as physical, emotional, spiritual, or social strength, depending on unique
coping strategies associated with ethnicity.
Among medical variables, the first finding was that a higher number of years
smoking was negatively correlated to PA, especially items of “active”, “alert”,
“determined”. The first two terms may reflect behaviors associated with smoking, such as
sedentary behavior (Strine et al., 2005). A person who has smoked for fewer years may
more highly endorse feeling determined, which may reflect quitting earlier or being
determined to reduce smoking. The CES-D PA (i.e., feeling happy, enjoying life) was
negatively associated with current number of packs per week and cigarettes per day, but
was not correlated with historical factors of smoking. Taken together, current smoking
habits seem to relate to emotional experiences related to engaging in life and feeling
happy, while history of smoking (i.e., years smoked) seem to relate to emotional
experiences that may more strongly reflect health-behavior type PA items (active, alert,
determined).
Second, current chemotherapy was negatively associated with PA, especially
items of “enthusiastic”, “inspired”, “strong”, “determined”, “interested”, and “active”.
Patients currently undergoing chemo are typically much more physically ill because of
side effects, so these findings are not surprising. On the CES-D, chemotherapy (current
and in the past two months) was negatively associated with enjoying life and feeling
hopeful about the future. Of course, chemotherapy requires frequent and lengthy
appointments at cancer treatment sessions for infusions, thus the large amount of time
spent in the hospital coupled with the difficult side effects would naturally make it very
difficult to enjoy life on a daily basis. However, because these items also correlated with
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chemotherapy status two months prior, these findings seem to capture some of the longerterm associations with treatment on mood and quality of life. Undergoing chemotherapy
serves as a stark reminder of the gravity of cancer, which may decrease patients’
hopefulness about the future in the immediate timing around that treatment as well as
several months after.
Other medical factors were not associated with PA, including cancer stage.
Similar to national averages, the majority (66%) of the patients in this sample were stage
III (n = 26) or IV (n = 14), with 23% of the sample being metastatic, thus limiting the
variance based on stage. This limited variance may have masked any differences in mood
based on stage.
In this sample, age at diagnosis may not have related to PA since the majority of
patients were older in age when they were diagnosed. There is a known preservation and
even increase of positive emotions with advancing age (Mroczek & Kolarz, 1998),
partially explained by improved emotion regulation over the lifespan (Carstensen, 1991;
Carstensen, 1995). Therefore, this known effect of age and positive emotion may
override any effects of age at diagnosis related to PA, given that age at study enrollment
and age at diagnosis were relatively similar and both later in life (61 vs. 59 years old).
Further, time since diagnosis may not have related to PA given that many of the patients
have not been recently diagnosed (i.e., within the past several months), thus any acute
effects on mood may have dissipated over time. Sixty percent of patients were diagnosed
in the past two years, with only seven patients being diagnosed in the past three months.
The lack of correlation between time since diagnosis and PA reflects the work of Duh,
Diener, and Fuhita (1996), who discovered that life events (good or bad) only affected
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happiness if they occurred in the previous two months. Thus the overall lack of
correlation between certain medical/demographic characteristics may reflect emotional
rebound that occurs after major life events (Diener, Lucas, Scollon, 2006).
Aim 2 Discussion: Positive Affect and Cortisol
Aim 2 focused on understanding the relationship between PA and diurnal cortisol
among the sample. In order to better understand the diurnal patterns of the current
sample and aid in discussion, several descriptive graphs were made post-hoc. Figure 10
shows the raw mean waking and bedtime cortisol values to create a graphic
representation of the overall diurnal slope. Graphically, the diurnal slope indeed shows a
descending pattern, indicating some maintenance of HPA rhythm. However, slope
change of raw cortisol scores of less than approximately 0.2 µg/dL is conventionally
considered flattened or aberrant (Sephton et al., 2000; Sephton et al., 2013). The overall
raw slope change observed in this sample (0.17 µg/dL) and demonstrated in Figure 10 is
nearly identical to the flattened pattern observed in a previous study of cortisol and early
mortality in lung cancer (Sephton et al., 2013). As such, Figure 10 suggests an overall
flattening of diurnal slope in this sample, despite a general decline from morning to
evening raw values.
Figure 11 qualitatively demonstrates the average “steep” vs. “flattened” diurnal
slope of the sample. In this figure, diurnal cortisol slope was split at the median slope
value and log mean waking and bedtime values were again graphed. The variability
among the waking the bedtime values among the steep and flattened slopes again
suggests an overall disruption of the HPA in this sample.
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To elucidate typical patterns observed in this sample, a third figure was created.
Figure 12 demonstrates three representative patterns of diurnal slope from three patients
in the sample: steep, flattened, and ascending. For descriptive purposes, relatively steep
slopes were qualitatively and conservatively categorized as a decline of 0.20 µg/dL from
raw waking to bedtime values; ascending were categorized as any increase from waking
and bedtime. About 36% of patients showed steep slopes, 52% showed flattened slopes,
and 13% had ascending slopes. These qualitative categorizations are similar to other
cancer samples with disrupted rhythms (Sephton et al., 2000). Further, when compared to
other cancer samples, patients in the current study seemed to have overall lower levels of
diurnal cortisol and overall flatter slopes (Table 31; Abercrombie et al., 2004; Cash et al.,
2015; Sephton et al., 2013).
Last, Figure 13 presents the raw mean waking and bedtime cortisol values for
patients who were taking corticosteroids versus those who were not. The graph
demonstrates that patients taking corticosteroids had lower raw waking values, thus
potentially contributing to an overall flattening of the diurnal slope. Such an effect is
consistent with research showing that corticosteroid use suppresses HPA activity
(Chourous, Pavlaki, & Magiakou, 2011).
The descriptive characterization of cortisol among the sample highlights the high
level of disruption of HPA rhythms evident at baseline. Research shows that 30-70% of
cancer patients display disruptions in diurnal cortisol rhythms, including uncoordinated
or erratic peaks and nadirs throughout the day, phase shifts, or generally flattened
patterns at either abnormally high or low levels (Sephton & Spiegel, 2003). Such patterns
are most evident in patients with high tumor burden, poor performance status, and liver
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metastases (Sephton & Spiegel, 2003). As such, disrupted cortisol rhythms may be an
indicator of progressing tumor status or the result of other biological effects of worsening
psychosocial functioning (e.g., poor sleep due to pain or anxiety; Eismann et al., 2003;
Sephton & Spiegel, 2003). Further, use of systemic corticosteroids can disrupt cortisol
levels through HPA suppression (Chourous, Pavlaki, & Magiakou, 2011). Thus,
associations among positive affect and cortisol may have been masked by the overall
disruption of the HPA at baseline, contributing disease-related variance that may have led
to the overall lack of findings for Aim 2 in this study.
Hypothesis 2.1. Aim 2 tested the relationships between positive affect and
cortisol variables, and hypothesis 2.1 stated that higher PA would be related to lower
mean cortisol levels. Hypothesis 2.1 was not supported.
Higher CES-D PA was associated with lower waking cortisol at a trend level. No
other significant findings or trends were observed with CES-D PA or PANAS PA and
mean cortisol levels. The CES-D PA finding remains interesting despite the other nonsignificant findings. Perhaps the CES-D PA items serve to capture PA in a contextual
sense. That is, CES-D may capture a sense of trait or even “lifestyle” positive affect –
enjoying life, feeling as good as others, feeling happy, being hopeful about the future;
while the PANAS-PA items don’t have as much of a sense of being placed in the context
of life (e.g., hopeful about the future vs. just hopeful).
Overall, higher PA was not related to overall mean diurnal cortisol, bedtime
cortisol, or waking cortisol. Similarly, negative affect also did not show strong
associations with cortisol means. Again, the lack of findings (for both PA and NA) may
be a result of the overall cortisol dysregulation already in place, masking any associations
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with psychosocial variables. Instead, other factors may have played a larger role
(behavior, tumor biology, medications) in cortisol levels.
As expected, higher log mean bedtime cortisol significantly correlated with older
age of diagnosis and more years of smoking. Also, raw mean bedtime cortisol was
observed to be higher at a trend level when a patient was currently receiving
chemotherapy treatment. Research shows that elevated bedtime cortisol is observed
among people with sleep disturbance and insomnia (Buckley and Schatzberg, 2005).
Research affirms that about 30-50% of newly diagnosed or recently treated oncology
patients report sleep disturbance and that this number is significantly higher than healthy
controls (Savard & Morin, 2001). Among lung cancer samples, clinical insomnia may be
present in about 30% of patients (Ginsburg et al., 1995; Sarna, 1993). Therefore, these
trend-level findings may hint towards a mechanism of cancer-related insomnia.
Hypothesis 2.2. The second hypothesis of Aim 2 stated that higher PA will be
related to steeper diurnal cortisol slope. Hypothesis 2.2 was not supported. In all
regressions, PA was not associated with diurnal slope.
However, when patients on corticosteroids were excluded from the sample, higher
NA was associated with flatter cortisol slopes (Figure 14). This finding mirrors research
demonstrating that depression is associated with flattened diurnal rhythms and disruption
of the HPA (Spiegel & Giese-Davis, 2003). As presence of NA (and lack of PA) is a core
feature of depression, it may be that NA (as a proxy of depressive symptoms) potentially
masks the effects of PA on slope in this subsample. Or, it may be that the patients with
higher NA were not experiencing sufficient levels of PA to combat depressive symptoms
(Folkman & Moskowitz, 2000), thus leading to an association with biology.
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Overall, the null findings regarding PA and slope in this sample may be a function
of other (stronger) influences on cortisol, such as medications (corticosteroids), sleep,
treatment effects, or tumor biology variables. Further, NA seemed to have a stronger
relationship to slope, suggesting the known strong biological effects of depressive
symptoms may mask contributions of PA on HPA function. As suggested in the
integrated model (Figure 1), eudaimonia and the experience of psychological well-being
may be more effective than PA on cortisol outcomes due to synergy among multiple
psychological resilience factors. The psychological resources of eudaimonia create
emotional resilience that interacts with appraisal, coping, and/or emotional responses.
This model is consistent with other stress-and-coping models of positive psychological
resilience factors, such as mindfulness (Salmon, Sephton, & Dreeben, 2011). Cancer
patients who demonstrate self-acceptance and have made meaning of their diagnosis may
appraise stressors as less threatening and cope more efficiently, thus avoiding the
biological disruption of chronic stress. Last, the null findings with cortisol slope may also
relate to variability in PA (Human et al., 2015), as coping with cancer likely is met with a
wide range of both positive and negative emotional experiences that may vary from day
to day.
Hypothesis 2.3. The third hypothesis of Aim 2 used path analysis to test whether
PA would more strongly relate to mean diurnal cortisol than to diurnal cortisol slope.
Hypothesis 2.3 was partially supported. In all three path analysis models, the beta
weight between PANAS PA and mean diurnal cortisol was consistently stronger than that
between PANAS PA and diurnal slope. Second, the beta weights were consistently in the
negative direction, suggesting an underlying pattern that higher PA (PANAS and CES-D)
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is associated with lower mean diurnal cortisol. These two points are in support of the
hypotheses. However, the path estimations were not statistically significant, thus firm
support of the hypotheses cannot be assumed. However, the findings support of the
proposed integrated model that PA may work to have an undoing effect on mean diurnal
cortisol, yet may need to be in conjunction with other resilience factors to more strongly
associate with robust cortisol slopes. The consistency of the direction and strength of the
beta weights among the models suggest that further investigation may be fruitful. The
lack of statistical significance but consistency in hypothesized direction of the path
estimates may suggest that the study is underpowered and that these pathways may reach
significance in a larger sample. Further, the fact that all of the predictor variable seemed
to be associated with flattened slopes again highlights that pre-existed cortisol
dysregulation may be present in the sample.
The models from the path analysis reflected the findings from the individual
regression analysis (beta weights remained consistent between analyses). However, the
benefit of these models is that they allow us to consider the effect of mood on both
cortisol variables at the same time. Model 1 presented the most simple path analysis,
using only the primary variables of interest. The model demonstrated poor fit, likely due
to the fact that PA did not relate strongly to either of the cortisol variables and explained
only a small portion of the variance in mean cortisol and cortisol slope. Fit improved
however when other variables were added to the path diagram, suggesting that these
elements help explain the cortisol variables.
Model 2 demonstrated the best overall fit of all of the models. All but one index
suggested good fit, with the exception of NFI. However, NFI tends to underestimate fit in
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small sample sizes, such as in this current study, which likely explains why it differed
from the other more robust fit indicators (Iacobucci, 2010). This again builds the case that
this current study may be underpowered for these analyses.
In Model 3, the CES-D PA variable demonstrated a stronger relationship (i.e.,
higher absolute value of beta weights) to the cortisol variables than the PANAS-PA. This
is consistent with the regression analyses of Aim 2. Although again these paths did not
reach statistical significance, it seems worthy to consider how the CES-D PA items may
be capturing positive psychological processes that are different, albeit correlated, to those
reflected in the PANAS-PA. Or, perhaps, the CES-D PA items mask the effects of the
PANAS-PA because they are highly correlated. That is, the CES-D items may capture a
superordinate positive psychological process that may mask the effects of the positive
affective states of the PANAS-PA. For example, a recent study on hedonia and
eudaimonia in ovarian cancer patients utilized structural equation modeling and found
that eudaimonia was associated with lower tumor norepinephrine, while PA was not,
despite the high correlation between eudaimonic well-being and PA (Davis et al., 2015).
Models 2 and 3 included PANAS NA. In both of these models, association
between NA and diurnal slope was stronger than between NA and mean diurnal cortisol
and between PA and diurnal slope. Although these paths were not statistically significant,
it may be possible that NA accounts for more variance in diurnal slope, thus masking any
effect of PANAS PA.
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STUDY LIMITATIONS
There are several limitations to the current study to be considered. As previously
mentioned, the study may have been underpowered to capture the nuanced relationships
between positive affect and biology. The relatively small sample size keeps us from
drawing large conclusions based on the findings. Further, the study did not include a
comparison group of healthy controls upon which to compare the nature of PA as well as
the potential relationships with the HPA.
Second, the study captured a sample that was mostly female, non-Hispanic White
patients, of lower socio-economic status. While this cohort of patients deserves attention,
the sample demographics limit the generalizability of the finding to more diverse patient
groups, in regard to gender, race, and income. Importantly however, since much research
is conducted among breast cancer patients/survivors, this current sample had relative
strength in including both male and female patients.
The current study had an enrollment criterion of having a diagnosis within the
past five years. However, five years time offers a wide range of psychological
experiences for patients. Newly diagnosed patients may have a radically different
emotional experience than those who are several years since diagnosis or early treatment.
Given this wide range of time and potentially different stages of coping among the
patients, associations among psychosocial and physiological factors may have been
masked by disease-related variance.
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Last, this study relied on self-report for all psychological measures. As with any
self-reported variable, one runs the risk of hindsight bias, variations in mood, and overall
difficulty in capturing true representation of an emotional experience. Further, the study
was limited to the positive affect measures that were included at the outset of the study,
which limited the range of PA measures to the PANAS and CES-D PA subscale.
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FUTURE DIRECTIONS
Many researchers note that the field would greatly advance from more research on
PA and neuroendocrine function, particularly among unhealthy samples (e.g., Chida &
Steptoe, 2008; Davis et al., 2015; Howell et al., 2007). Several avenues of future
research may improve the quality of research and address several points derived from this
current work. First, studies should seek to include broad measures of PA – both hedonic
and eudaimonic – to be able to deeply explore the quality and outcomes of these complex
emotional experiences among cancer patients. Studies should seek to use similar and
standardized measures of PA and consistent terminology. Clarification of whether PA
measured is state or trait will also help to untangle short-term versus long-term
associations with biology, and will help parse out potential overlap with confounding
variables. Positive affect measurements and study designs should also seek to elucidate
the role of arousal and PA variability (Hoyt et al., 2015; Human et al., 2015). Underlying
mechanisms of positive mood, such as the fighting spirit, adaptive coping, and social
support, may render fruitful avenues for broadening the understanding of positive
psychological processes in mind-body medicine.
Similarly, close attention to subtypes of positive mood may seem to play a
particularly important role in physical well-being. In particular, a recent large-scale study
(N = 5,554) found that low PANAS PA was significantly associated with mortality, and
this finding was equally as strong among cancer-related and cardiovascular-related deaths
(Petrie et al., 2018). Importantly, the PANAS PA item “active” largely explained this
finding (Petrie et al., 2018). Given that “active” was significantly associated with
smoking and chemotherapy status in this sample, future research may explore the role of
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sedentary behavior and its physical and mental effects among lung cancer patients.
Overall, the relationship between specific positive emotions and modifiable health
behaviors in the context of cancer prevention and control warrants greater attention.
Second, future studies should employ reliable cortisol calculation and collection
methods and report on multiple cortisol outcomes. Such rigor may highlight differential
pathways and mechanisms, and clarify the relationships between overall secretion, slope,
and CAR, and related clinical outcomes. The use of standardized collection times and
measures will help to reduce variation between study designs, and will facilitate more
reliable cross-study comparisons.
Third, future studies should seek to enroll larger, diverse samples, with a
comparison group of healthy controls. Such studies may wish to focus on a certain time
point since diagnosis (e.g., within months as opposed to years) to capture more specific
associations between mood and biology. Future studies may also benefit from using
ecological momentary assessment to capture a more accurate picture of the patients’
positive mood states, as well as their variability within-person.
Fourth, more studies should also be conducted within the lung cancer population.
The vast majority of cancer research, and all of the current PA and cortisol research
among cancer samples, is among breast cancer patients. Given the implications for
coping, meaning-making, and resilience factors, the field would benefit from research in
highly distressed cancer populations, such as lung cancer. Building this body of research
lends practical utility in psychological and medical care domains, and highlights the
importance of granting cancer patients greater access to psychologists. Future
psychosocial interventions for cancer patients may seek to promote authentic and realistic
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experiences of PA, while simultaneously building psychological resources to create
eudaimonic well-being. Research on mindfulness-based therapies shows that this may be
a promising avenue for linking PA, eudaimonia, and cortisol (Jimenez, Niles, & Park,
2010; Tang et al., 2007).
Fifth, in considering the roles of NA and PA, special attention must be paid to
confounding effects of syndromal and subsyndromal depression. Such symptoms
commonly co-occur in cancer patients (Spiegel & Giese-Davis, 2003). Importantly,
depression has prognostic significance among lung cancer patient (Pirl et al., 2012), and
even subclinical levels can be associated with early mortality in cancer (Zimmaro et al.,
2017). Depression is characterized not only by presence of NA, but lack of PA (Folkman
& Moskowitz, 2000; Radloff, 1977). Depression also has known associations with HPA
dysregulation (Currier & Nemeroff, 2014). Therefore, future studies should carefully
ensure analyses control for the effects NA when testing the associations of PA with
cortisol in cancer patients. Further, special attention should be made to the experiences of
shame and guilt in this population, given that these experiences may be qualitatively
different among different cancer types. Future studies may also wish to utilize the ratio of
positive to negative affect (Critical Positivity Ratio; Fredrickson & Losada, 2005) as
deeper exploration of the relationship between positive and negative emotions within this
population.
Last, future research should continue to explore the proposed pathways of the
integrated model outlined at the outset (Figure 1). Direct effects should first be examined.
Moderators of the model should also be tested, with particular attention to individual
difference factors and cancer-related variables. Mediational analyses might examine the
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neurobiological pathways of hedonia and eudaimonia in cancer patients, especially
pathways that involve the HPA. Controlled experiments could explore the undoing and
buffering hypotheses as outlined in the model. Last, the clinical significance of cortisol
total secretion as it relates to survival, prognosis, or other tumor-relevant factors deserves
greater attention.
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FINAL CONCLUSIONS
The blossoming research on positive psychology is making its way into policy on
a national and global scale, and indeed this progress is moving into the healthcare field.
In 2015, the World Health Organization launched a series of Sustainable Development
Goals, aimed to increasing health and well-being on a global scale (World Health
Organization, 2016). However, specific efforts within the cancer field have yet to be
established, allowing for large-scale opportunities of growth in this area.
This current research highlighted that while typically lung cancer patients are
considered some of the most distressed cancer patients, they are also experiencing
positive and resilient emotions. While the biological associations of these emotions may
have been masked by tumor-relevant physiological disruption, the everyday experience
of positive states may have considerably increased a patient’s quality of life. In the face
of a terminal illness, it may not be the quantity of life that matters the most, but rather,
the quality of the days left.
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Tables
Table 1
Studies with Cancer Samples, PA, and Cortisol
Cancer
Sample

PA Measure

PA Conceptual Cortisol
Framework
Measure/Methods

Porter et
al., 2003

Breast
cancer
survivors
(n=33) vs.
healthy
controls
(n=21)

Four PA adjectives,
rated 0-6 Likert scale.
Measured 3x/day
(midmorning,
midafternoon, evening)
on each day of data
collection. Items were
summed over the three
days.

Hedonic, trait
(baseline,
before
mammogram),
state (stressor
days of
mammogram)

GieseDavis,
DiMiceli,
Sephton,
& Spiegel,
2006

Metastatic
breast
cancer
patients
(N=29)

Coded video-recorded
PA expression during
therapy session; PA
expression included
affection (verbal and
touch), interest,
validation, accurate

Hedonic, state
(may also be
trait if
expression is
thought of as
personality
trait)
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Authors,
Year

Association
Between PA
and Cortisol
Salivary; 6
Higher
samples/day, at two
baseline PA
timepoints:1) three
was associated
consecutive days one with lower
month prior to
cortisol
mammogram, 2) day
reactivity to
before, day of, and day mammogram
after procedure.
Measures were
average cortisol level,
diurnal slope, and
cortisol reactivity
(slope change score
from time 1 to time 2)
Salivary; 4 samples
per day (8:00, 12:00,
17:00, 21:00h), for 3
consecutive days.
Diurnal cortisol slope
and mean cortisol level
were used in analyses.

PA expression
associated with
lower mean
cortisol levels,
even when NA
expression was
controlled for.

Other
Notable
Findings
Breast cancer
survivors had
higher
baseline
cortisol, but
no differences
in slope or
CAR

emotions, genuine
humor,
excitement/joy/delight
Metastatic PANAS, measured as
breast
state during Trier Social
cancer
Stress Test (TSST)
patients
(N=90): 45
depressed,
45 nondepressed

Hedonic, state

Salivary; 5 samples
Relationship
per day (waking,
not directly
+30mins, 12:00h,
measured
17:00h, 21:00h) for 2
consecutive days, 1
week prior to TSST
and day after TSST. 10
salivary samples
throughout TSST.
Diurnal slope, waking
levels, CAR, and
recovery levels of
evening, next day
waking and CAR
(baseline levels minus
levels after TSST)

Depressed
patients had
lower waking
cortisol levels
and lower PA
at TSST.

Costanzo
et al.,
2012

Breast
cancer
survivors
(n=111),
healthy
controls
(n=111)

Daily telephone
Hedonic, trait
interview for 8
(average of 8
consecutive days; rated days)
frequency (5point scale)
of 13 PA items
experienced that day.
Ratings were averaged to
obtain overall PA
measure.

Salivary; 4 samples
Relationship
per day (waking,
not directly
waking+30mins,
measured
before lunch, before
bed), for 4 consecutive
days. Measures were
diurnal slope, total
output (AUC), and
CAR slope

Patients rated
daily stressors
as more
disruptive.
More time
since
diagnosis was
associated
with more PA,
and less total
cortisol. On
stressor days,
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GieseDavis,
Wilhelm
et al.,
2006

but not PA,
related to
cortisol slope.

cancer
survivors
declined less
PA, had less
overall
cortisol
output, but
similar
patterns of
slope and
CAR as
healthy
controls.
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Table 2
Sample Demographics
Variable

Levels

Frequency
(n)

Percent of
Sample (%)

Gender

Male
Female

20
41

32.8
67.2

Race

Black or African
American
White

13

21.3

48

78.7

Education
Completed

Middle School (7-8
years)
High School (12 years)
AA/Technical (14 years)
BA/BS (16 years)
MA/MS (18 years)

4

6.6

34
16
4
3

55.7
26.2
6.6
4.9

Income

<$15,000
%15,001-$19,999
$20,000 - $29,999
$30,000 -$39,999
$40,000 - $49,000
$50,000 - $59,999
$60,000 - $69,999
$70,000 - $79,999
$80,000 - $89,000
$90,000 - $99,999
$100,000 - $149,999
$150,000 - $249,999

17
5
9
4
7
1
6
1
2
1
4
1

27.9
8.2
14.8
6.6
11.5
1.6
9.8
1.6
3.3
1.6
6.6
1.6

Age
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Mean
(SD)
60.8 (

Table 3
Cancer Staging and Diagnosis Variables
Variable
Age at diagnosis

Levels Frequency
(n)

Percent of
Sample (%)

I
II
III
IV
No
Yes

23
11.5
42.6
23
29.5
70.5

Time since diagnosis (months)
Summary stage

Diagnosed with other medical
condition

14
7
26
14
18
43
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Mean (SD)
58.97
(8.76)
22.28
(17.32)

Table 4
	
  
Patients’ Current Medications
Medication Type
Adrenals
Anti-convulsants
Anti-depressants
Anxiolytics
Benzodiazepine
Systemic Contraceptives
Corticosteroids
Estrogens
Opiate Agonists
Tranquilizers
Sedatives/Tranquilizers
Sleep aids

Frequency (n)
0
7
15
0
10
0
20
3
17
0
0
5
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Percent of Sample (%)
0
11.5
24.6
0
16.4
0
32.8
4.9
27.9
0
0
8.2

Table 5
Smoking History
Smoking Variable

Mean (SD)

History of Smoking
(including current)
Currently smoke
cigarettes

Levels

Frequency (n)

Percent of
Sample
(%)

No

2

3.3

Yes

59

96.7

No

44

72.1

Yes

16

26.2

Current Smokers (n=16)
Current packs per week

3.12 (3.17)

Current cigarettes per day

11.28 (8.91)

How many years have you 39.54 (15.24)
been smoking
Patients with a Smoking History (Including Current Smokers; n=59)
History of smoking
cigarettes
How many years did you
smoke?

36.11 (12.12)

Years since quitting
smoking

8.08 (9.14)

How many packs/week
did you smoke?

7.76 (4.93)

How many cigarettes/day
did you smoke?

22.66 (12.94)

Pack Years (Current)
(packs/day x years
smoking)

20.00 (14.35)

Pack Years (History)

42.07 (29.47)

Total Pack Years

41.43 (30.05)

No

2

3.3

Yes

59

96.7
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Table 6
Cancer Treatment Variables
Variable

Level Frequency
(n)
No
12
Yes
48

Percent of Sample
(%)
19.7
78.7

Are you currently receiving chemo?

No
Yes

38
21

62.3
34.4

Have you received chemo in the past 2
months?

No
Yes

34
22

55.7
36.1

Have you ever received radiation?

No
Yes

22
38

36.1
62.3

Are you currently receiving radiation?

No
Yes

57
3

93.4
4.9

Have you received radiation in the past two
months?

No
Yes

50
7

82.0
11.5

Have you ever received chemo?
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Table 7
Positive and Negative Affect Descriptives
Scale
PANAS – Positive Affect Items
Interested
Excited
Strong
Enthusiastic
Proud
Alert
Inspired
Determined
Attentive
Active
PA Subscale Mean
PA Total Score

Mean (SD)

Score Range

3.16 (1.05)
2.64 (1.08)
2.85 (1.11)
2.64 (1.17)
2.87 (1.43)
3.26 (1.14)
2.59 (1.24)
3.31 (1.15)
2.97 (1.13)
2.93 (1.06)
2.92 (0.83)
29.24 (8.30)

1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1.10-4.70
11-47

PANAS – Negative Affect Items
Distressed
Upset
Guilty
Scared
Hostile
Irritable
Ashamed
Nervous
Jittery
Afraid
NA Subscale Mean
NA Total Score

2.13 (1.06)
2.15 (1.18)
1.46 (0.91)
2.10 (1.31)
1.43 (0.83)
2.38 (1.21)
1.40 (0.86)
2.45 (1.35)
2.11 (1.27)
2.10 (1.43)
1.97 (0.82)
19.71 (8.21)

1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-5
1-4
10-40

CES-D – Positive Items
Felt I was just as good as other people
Felt hopeful about the future
I was happy
I enjoyed life
CES-D Positive Items Mean
CES-D PA Total Score

2.31 (0.92)
1.81 (1.04)
2.14 (0.82)
2.31 (0.90)
2.14 (0.74)
8.57 (2.98)

0-3
0-3
0-3
0-3
0.25–3.00
1-12

Note. PA = positive affect; NA = negative affect
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Table 8
Two-Factor Pattern Matrix
Factor
PANAS Items

1

2

PA Items
interested

.152

.535

excited

.214

.441

strong

-.133

.748

enthusiastic

.011

.667

proud

-.141

.686

alert

.159

.623

inspired

-.230

.816

determined

.060

.725

attentive

.016

.770

active

.094

.758

distressed

.755

-.086

upset

.827

.058

guilty

.326

.131

scared

.694

-.025

hostile

.605

-.054

irritable

.742

-.184

ashamed

.370

.005

nervous

.748

.148

jittery

.702

.087

afraid

.826

.050

NA Items

Note. Extraction Method: Principal Axis Factoring. Rotation Method: Promax with
Kaiser Normalization. Item loadings are bolded for each appropriate factor.
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Table 9
Three-Factor Pattern Matrix
Factor
PANAS Items

1

2

3

PA Items
interested

.542

.168

-.039

excited

.422

.112

.225

strong

.744

-.139

.007

enthusiastic

.673

.032

-.053

proud

.715

-.047

-.221

alert

.613

.107

.113

inspired

.802

-.292

.128

determined

.729

.074

-.036

attentive

.791

.081

-.149

active

.742

.017

.167

distressed

-.057

.862

-.195

upset

.075

.857

-.050

guilty

.066

.040

.694

scared

-.020

.676

.044

hostile

-.053

.576

.067

irritable

-.184

.701

.099

ashamed

-.091

.027

.873

nervous

.163

.769

-.037

jittery

.085

.658

.101

afraid

.051

.784

.093

NA Items

Note. Extraction Method: Principal Axis Factoring. Rotation Method: Promax with
Kaiser Normalization. Item loadings are bolded for each appropriate factor.
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Table 10
Five-Factor Pattern Matrix
PANAS
Items

Factor
1

2

3

4

5

PA items
interested

.118

.358

-.073

.251

.326

excited

.051

-.012

.178

.682

.206

strong

-.182

.703

.008

.062

.311

enthusiastic

.051

.299

-.115

.583

-.048

proud

.002

.480

-.245

.350

-.156

alert

.151

.533

.126

.185

-.179

inspired

-.277

.579

.104

.348

-.001

determined

.087

.859

.011

-.153

.065

attentive

.107

.866

-.120

-.094

.038

active

.033

.844

.224

-.071

-.025

distressed

.882

.133

-.166

-.278

.024

upset

.871

.026

-.051

.103

-.051

guilty

.019

.045

.647

.146

.064

scared

.606

-.109

.003

.103

.483

hostile

.596

-.105

.072

.121

-.135

irritable

.765

-.093

.132

-.071

-.278

ashamed

.007

.028

.927

-.006

-.112

nervous

.718

.116

-.042

.067

.271

jittery

.626

.202

.128

-.139

.181

afraid

.734

-.157

.046

.313

.281

NA Items

Note. Extraction Method: Principal Axis Factoring. Rotation Method: Promax with
Kaiser Normalization. Item loadings are bolded for the appropriate factor.
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Table 11
Cortisol Variable Descriptives
Cortisol Variable

Mean (SD)

Range

Raw Waking Cortisol (µg/dL)

0.289 (.133)

0.013 – 0.745

Log Waking Cortisol, log(µg/dL)

-1.553 (.756)

-5.097 – -0.342

Raw Bedtime Cortisol (µg/dL)

0.119 (.093)

0.011 – 0.447

Log Bedtime Cortisol, log(µg/dL)

-2.840 (.946)

-5.841 – -1.190

Log Diurnal Mean, log(µg/dL)

-2.189 (.666)

-4.738 – -1.168

Diurnal Slope, log(µg/dL)/Hr

-0.049 (.107)

-0.257 – 0.305

Raw Slope (µg/dL)

0.170 (.151)

-0.18 – 0.63

Note. Raw slope is the change score between raw bedtime and raw waking cortisol
values. Positive values indicate a descending slope.
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Table 12
PANAS-PA and Data-Driven Controls Regressed onto Mean Diurnal Cortisol
Variable
β
t
p
Step 1
PANAS-PA -.088 -.658 .513
Note. sr = semipartial correlation

sr
-.088

R
.008

103

R2
.008

ΔR2

p (ΔR2)

F
.433

p
.513

Table 13
PANAS-PA and Theoretically-Driven Controls Regressed onto Mean Diurnal Cortisol
Variable
β
t
p
Step 1
PANAS-NA .044 .336
.738
Steroid -.253 -1.925 .060
Step 2
PANAS-NA .064 .485
.630
Steroid -.276 -2.071 .043*
PANAS-PA -.141 -1.045 .301
Note. sr = semipartial correlation

sr
.044
-.253
.064
-.272
-.137
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R
R2 ΔR2 p (ΔR2)
F
p
.256 .064 .065 .161
1.889 .161
.290 .084 .019 .301

1.626 .194

Table 14
PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Mean Diurnal
Cortisol
Variable
β
t
p
Step 1
PANAS-PA .019 .126
.901
CES-D-PA -.242 -1.607 .114
Note. sr = semipartial correlation

sr
.017
-.217

R
.234

105

R2
.055

ΔR2

p (ΔR2)

F
1.506

p
.231

Table 15
PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Mean Diurnal
Cortisol
Variable
β
t
p
Step 1
PANAS-NA .044 .330
.743
Steroid -.253 -1.889 .065
Step 2
PANAS-NA .012 .089
.929
Steroid -.258 -1.908 .062
PANAS-PA -.035 -.223 .825
CES-D PA -.216 -1.404 .167
Note. sr = semipartial correlation

sr
.044
-.253
.012
-.253
-.030
-.186

R
R2
.256 .065

ΔR2

.345 .119

.054 .229

106

p (ΔR2)

F
1.819

p
.172

1.688

.167

Table 16
PANAS-PA and Data-Driven Controls Regressed onto Waking Cortisol
Variable
β
t
p
Step 1
PANAS-PA -.057 -.422 .675
Note. sr = semipartial correlation

sr
-.057

R
.057
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R2
.003

ΔR2

p (ΔR2)

F
.178

p
.675

Table 17
PANAS-PA and Theoretically-Driven Controls Regressed onto Waking Cortisol
Variable
β
t
p
Step 1
PANAS-NA .028 .214
.831
Steroid -.300 -2.308 .025*
Step 2
PANAS-NA .044 .334
.739
Steroid -.318 -2.409 .020*
PANAS-PA -.113 -.847 .401
Note. sr = semipartial correlation

sr
.029
-.300
.044
-.314
-.116
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R
R2
.300 .090

ΔR2

p (ΔR2)

.320 .102 .012 .401

F
p
2.672 .078
2.011 .124

Table 18
PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Waking Cortisol
Variable
β
t
p
Step 1
PANAS-PA .071 .477
.635
CES-D-PA -.292 -1.934 .053
Note. sr = semipartial correlation

sr
.064
-.259

R
.265

109

R2
.070

ΔR2

p (ΔR2)

F
1.960

p
.151

Table 19
PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Waking
Cortisol
Variable
β
t
p
Step 1
PANAS-NA .028 .210
.834
Steroid -.300 -2.264 .028*
Step 2
PANAS-NA .021 -.153 .879
Steroid -.295 -2.232 .030*
PANAS-PA .019 -.127 .900
CES-D PA -.269 -1.786 .080
Note. sr = semipartial correlation

sr
.028
-.300
-.020
-.290
.016
-.232
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R
R2
.300 .090

ΔR2

p (ΔR2)

.395 .156 .066 .152

F
p
2.573 .086
2.311 .070

Table 20
PANAS-PA and Data-Driven Controls Regressed onto Bedtime Cortisol
Variable
β
t
Step 1
Age at Diagnosis .230 1.472
Years Smoking .182 1.167
Step 2
Age at Diagnosis .229 1.432
Years Smoking .184 1.100
PANAS-PA .005 .035
Note. sr = semipartial correlation

p

sr

.148 .198
.249 .157
.159 .195
.277 .150
.973 .005
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2

2

R
R
ΔR
.359 .129

p
(ΔR2)

.359 .129 .000 .973

F
p
3.545 .037*
2.315 .088

Table 21
PANAS-PA and Theoretically-Driven Controls Regressed onto Bedtime Cortisol
Variable
β
t
Step 1
Age at .028
1.608
Diagnosis
Years Smoking .015
1.202
PANAS-NA .012
.745
Steroid -.285
-1.050
Step 2
Age at .029
1.607
Diagnosis
Years Smoking .014
1.041
PANAS-NA .012
.766
Steroid -.295
-1.063
PANAS-PA -.004
-.237
Note. sr = semipartial correlation

p

sr

.115 .218
.236 .163
.460 .101
.299 -.142
.115 .220
.303
.448
.293
.814

.142
.105
-.145
-.035
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2

R
R
.397 .158

2

ΔR

p
(ΔR2)

.398 .159 .001 .814

F
p
2.154 .089

1.699 .154

Table 22
PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Bedtime Cortisol
Variable
β
t
Step 1
Age at .230
1.472
Diagnosis
Years Smoking .182
1.167
Step 2
Age at .223
1.384
Diagnosis
Years Smoking .197
1.163
PANAS-PA .059
.364
CES-D PA -.114
-.743
Note. sr = semipartial correlation

p

sr

.148 .198
.249 .157
.173 .189
.251 .159
.717 .050
.461 -.102

113

2

R
R
.359 .129

2

ΔR

p
(ΔR2)

.373 .139 .010 .760

F
p
3.545 .037*

1.857 .134

Table 23
PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Bedtime
Cortisol
Variable
β
t
Step 1
Age at .257
1.608
Diagnosis
Years Smoking .189
1.202
PANAS-NA .103
.745
Steroid -.143
-1.050
Step 2
Age at .255
1.527
Diagnosis
Years Smoking .186
1.082
PANAS-NA .089
.596
Steroid -.141
-1.001
PANAS-PA .005
.028
CES-D PA -.075
-.466
Note. sr = semipartial correlation

p

sr

.115 .218
.236 .163
.460 .101
.299 -.142
.124 .211
.285
.554
.322
.978
.643

.149
.082
-.138
.004
-.070

114

R
R2
.397 .158

ΔR2

p
(ΔR2)

.404 .163 .005 .873

F
p
2.154 .089

1.427 .226

Table 24
PANAS-PA and Data-Driven Controls Regressed onto Diurnal Cortisol Slope
Variable
β
t
p
Step 1
PANAS-PA .08
.594 .555
Note. sr = semipartial correlation

sr
.080

R
.080

115

R2
.006

ΔR2

p (ΔR2)

F
.353

p
.555

Table 25
PANAS-PA and Theoretically-Driven Controls Regressed onto Diurnal Cortisol Slope
Variable
β
t
p
Step 1
PANAS-NA .116 1.250 .217
Steroid .154 1.164 .250
Step 2
PANAS-NA .153 1.139 .260
Steroid .168 1.244 .219
PANAS-PA .085 .623
.536
Note. sr = semipartial correlation

sr
.166
.154
.152
.166
.083

116

R
R2
.230 .053

ΔR2

p (ΔR2)

.245 .060 .007 .536

F
p
1.509 .230
1.24

.348

Table 26
PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Diurnal Cortisol
Slope
Variable
β
t
p
Step 1
PANAS-PA .010 .062
.950
CES-D-PA .158 1.038 .304
Note. sr = semipartial correlation

sr
.009
.142

R
.163

117

R2
.027

ΔR2

p (ΔR2)

F
.709

p
.497

Table 27
PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Diurnal
Cortisol Slope
Variable
β
t
p
Step 1
PANAS-NA .166 1.227 .225
Steroid .154 1.142 .259
Step 2
PANAS-NA .203 1.432 .158
Steroid .151 1.099 .277
PANAS-PA -.015 -.095 .925
CES-D PA .204 1.303 .199
Note. sr = semipartial correlation

sr
.166
.154
.193
.148
-.013
.181

118

R
R2
.230 .053

ΔR2

p (ΔR2)

.301 .091 .038 .361

F
p
1.453 .243
1.247 .303

Table 28
Exclusion of Patients on Corticosteroids: PANAS-PA and Theoretically-Driven Controls
Regressed onto Diurnal Cortisol Slope
Variable
β
t
p
Step 1
PANAS-NA .302 1.901 .065
Step 2
PANAS-NA .295 1.805 .080
PANAS-PA .038 .232
.818
Note. sr = semipartial correlation

sr
.302
.292
.037
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R
R2
.302 .091

ΔR2

p (ΔR2)

.304 .093 .001 .818

F
p
3.613 .065
1.786 .183

Table 29
Exclusion of Patients on Corticosteroids: PANAS-PA, CES-D PA and TheoreticallyDriven Controls Regressed onto Diurnal Cortisol Slope
Variable
β
t
p
Step 1
PANAS-NA .302 1.874 .069
Step 2
PANAS-NA .379 2.170 .037*
PANAS-PA -.085 -.457 .651
CES-D PA .261 1.380 .177
Note. sr = semipartial correlation

sr
.302
.350
-.074
.222
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R
R2
.302 .091

ΔR2

p (ΔR2)

.377 .064 .051 .387

F
p
3.512 .069
1.822 .162

Table 30
Hypotheses and Findings Summary
Hypothesis
Aim 1
Understand the frequency and quality of PA among
lung cancer patients
1.1
Patients will experience moderate PA and will report
more PA than NA.
1.2
Positive and negative affect items will emerge as
separate factors.
1.3
Variables that reflect lower disease burden will be
associated with higher PA.

Finding
Supported
Supported
Partially Supported

Test the relationship between positive affect and
cortisol variables
2.1
Higher PA will be related to lower mean cortisol
Not Supported1
levels.
2.2
Higher PA will be related to steeper diurnal cortisol
Not Supported2
slope.
2.3
PA will more strongly relate to mean cortisol than to
Partially
diurnal slope.
Supported3
Note. Superscript indicates significant or trend findings for relevant hypothesis. 1 Higher
CES-D PA was associated with lower waking cortisol at a trend level. 2 Higher NA was
associated with flatter slopes when not including patients on corticosteroids. 3 Absolute
values and direction of beta weights were in hypothesized directions, but did not reach
statistical significance.
	
  
Aim 2

121

Table 31
Comparison of Cortisol Variables to Other Research Samples
Cortisol Variable

Cortisol Mean (SD) in Comparative Samples
Current
Lung
Breast
Metastatic
Healthy
Sample
Cancer
Cancer
Breast Cancer
Sample
Mean Waking Value, -1.553
NR
-1.330
NR
NR
log(µg/dL)
(0.76)
(0.54)
Mean Bedtime
Value, log(µg/dL)

-2.840
(0.95)

NR

-2.791
(0.99)

NR

NR

Diurnal Cortisol
Mean, log(µg/dL)

-2.189
(0.67)

NR

-1.213
(0.39)

-1.22
(0.39)

-1.27
(0.46)

Diurnal Slope,
log(µg/dL)/Hr

-0.049
(0.11)

-0.114
(0.06)

-.071
(0.09)

-0.092
(0.03)

-0.113
(0.03)

Note. NR = not reported. Lung cancer sample statistics are from Sephton et al., 2013.
Breast cancer sample statistics are from Cash et al., 2015. Metastatic breast cancer
sample and healthy sample statistics are from Abercrombie et al., 2004.
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Figures
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Figure 1. An integrated model of PA and cortisol in cancer patients. Lettered arrows
indicate processes and relationships. Arrow A: Cancer is associated with psychological
distress (stress). Arrows B and C: Stress influences the areas of the cortex, limbic system,
and HPA, which interact to result in the release of cortisol (total cortisol level, diurnal
slopes, CAR; Arrow D). Arrows E and F: Neuroimaging literature indicates that PA and
eudaimonia influence brain structures involved in regulating HPA system. Arrow G: PA
encourages eudaimonia in cancer through the Broaden and Build Theory. Arrow H:
Based on the Undoing Hypothesis, patients’ PA undoes effects of acute stress on the
HPA (H1), leading to a lower total cortisol levels and reactivity (H2). Arrow I: Based on
the Buffering Hypothesis, eudaimonia buffers effects of chronic stress through building
psychological resources (I1), influencing more robust cortisol outcomes like diurnal
slopes. Arrows J and K: Neuroendocrine and immune processes interact to influence
health outcomes.
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Figure 2. Hypothesized relationships for current study. Figure demonstrated proposed
pathways to be tested in a sample of lung cancer patients. Pathway to be tested is adapted
from arrow H2 from Figure 1. Hypothesis 1 states that positive affect will be associated
with lower mean cortisol variables. Hypothesis 2 states that positive affect will be
associated with steeper diurnal slope.
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Figure 3. Mean score for each positive and negative affect item on the PANAS. Scores
reflect the extent to which patients felt each of the emotions over the past week. Each
item was endorsed on a 1-5 Likert scale of very slightly or not at all to extremely. Item
means are presented in descending order. Solid bars represent the positive affect items;
striped bars represent the negative affect items.
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Figure 4. Scree plot from factor analysis of PANAS items. Scree plot demonstrates
points of inflexion (bolded dots) at the third, fourth, and sixth factor numbers, suggesting
a two, three, or five factor solution may be most appropriate for the data.	
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Figure 5. Factor plot in rotated factor space showing two-factor solution. PANAS PA
and NA items strongly loaded onto the respective PA and NA subscales identified on the
standardized measure.
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Figure 6. Factor plot in rotated factor space showing three-factor solution. PANAS PA
items remained as their own factor (open circles). NA items fell into two factors, with
NA items of “ashamed” and “guilty” loading independently onto a separate factor (red
circles) from the rest of the NA items (closed black circles).
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Figure 7. Model 1 path analysis. Standardized regression weights are displayed on

arrows from PANAS PA to cortisol variables. Squared multiple correlations are displayed
above the endogenous variables. The correlation between the error terms is displayed on
the double arrow. No relationships were statistically significant.
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Figure 8. Model 2 path analysis. Standardized regression weights are displayed on

arrows from control variables (glucocorticoid use, PANAS NA) and PANAS PA to
cortisol variables. Squared multiple correlations are displayed above the endogenous
variables. The correlation between the error terms is displayed on the double arrow.
Glucocorticoid use was negatively associated with mean diurnal cortisol (p = .030); no
other relationships were statistically significant.
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Figure 9. Model 3 path analysis. Standardized regression weights are displayed on
arrows from control variables (glucocorticoid use, PANAS NA) and PANAS PA to
cortisol variables. Squared multiple correlations are displayed above the endogenous
variables. The correlation between the error terms is displayed on the double arrow.
Glucocorticoid use was negatively associated with mean diurnal cortisol (p = .046); no
other relationships were statistically significant.
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Raw Mean Diurnal Cortisol
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Figure 10. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels
(µg/dl) at waking and bedtime for overall sample. Mean diurnal slope for the sample
equaled -0.049 log(µg/dl)/Hr.
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Cortisol Means Above and Below Median Cortisol Slope
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Figure 11. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels
at waking and bedtime for two groups of patients split at the median diurnal slope (-0.05
log (µg/dl)/Hr). Mean slope for flat slope group (n=28) was 0.028 log(µg/dl)/Hr and for
the steep slope group (n=29) it was -0.123 log(µg/dl)/Hr.
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Example Cortisol Patterns
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Figure 12. Raw mean diurnal salivary cortisol levels at waking and bedtime for three
study participants with representative cortisol profiles observed: flattened descending
slope (open square), steep slope, flattened ascending (closed triangle).
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Mean Diurnal Cortisol Values Split by Corticosteroid Use
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Figure 13. Raw mean salivary cortisol levels at waking and bedtime, split by patients
who were taking corticosteroids versus those who were not. Patients on corticosteroids
appear to have lower mean morning values; although, cautious interpretation is
warranted, given the large standard deviations.	
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Cortisol Means Above and Below Median NA
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Figure 14. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels
at waking and bedtime for two groups of patients split at the median NA score (NA =
18). Patients in this figure are not taking corticosteroids (n = 41). The group with less NA
(n = 20, M = 12.15) had steeper slopes (-0.094 log(µg/dl)/Hr) than the group with more
NA (n = 21, M = 26.05; slope = -0.031 log(µg/dl)/Hr).
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